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FOREWORD

This dissertation, divided into four chapters, is concerned with the
interaction of w ater soluble cigarette smoke particulate phase com ponents
with human alpha-1-proteinase inhibitor. Chapter 1 is a comprehensive
introduction covering material from the literature related to the studies in
this dissertation. Chapter 2 deals with both the basic features of the
"aqueous cigarette tar extract" and the assay of alpha* 1-proteinase
inhibitor activity. Chapter 3 covers mechanistic studies on the nature of
the species in aqueous cigarette tar extract that dam age alpha-1-proteinase
inhibitor. Chapter 4 presents studies on the structural dam age to alpha-1 proteinase inhibitor by aqueous cigarette tar extract. Much of the material
in this dissertation has been published or is being prepared for publication
in the scientific literature.
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ABSTRACT

The effect, in vitro, of w ater soluble com ponents of th e particulate
phase of cigarette smoke on the elastase inhibitory capacity (EIC) of human
alpha-1-proteinase inhibitor (or,PI) is studied. Basic features of aqueous
cigarette tar extract-mediated dam age to o,PI are presented, as are
m echanistic studies addressing the identities of damaging species and the
nature of dam age to a,PI.
Aqueous cigarette tar extract (ACT) ca u ses a slow loss of EIC, and
retains this o,PI damaging ability for hours. The dam age to o,PI by ACT is
d ep end en t on its hydrogen peroxide content. Hydroxyl radicals or
hypervalent metal species in the hom ogeneous phase of ACT do not
dam age a yP\, which is compatible with their high reactivity and poor
selectivity. Hydrogen peroxide accounts for the major portion of the
dam age to ACT-exposed a,PI, probably by direct oxidation of critical
methionyl residues. Free methionine, but not methionine sulfoxide,
protects against dam age to o,PI by ACT. Also, ACT-exposed o,PI contains
appreciable methionine sulfoxide. The a,PI exposed to ACT also undergoes
non-oxidative modification to produce a more anionic protein, but such
modification does not contribute to the loss of EIC.
Hydrogen peroxide, at concentrations relevant to th o se produced in
ACT, cau ses a comparable rate of loss of EIC and appreciable formation of

xiv

methionine sulfoxide in or, PI. However, hydrogen peroxide does not
reproduce th e non-oxidative modifications of ACT-exposed a,PI. Although
exposures of a,PI to catechol/hydroquinone show s som e similarities to
ACT, it is generally a poorer model com pared to hydrogen peroxide.
Sulfhydryls and ascorbate protect o,PI in ACT due to various factors,
such as direct reaction with hydrogen peroxide. Chelators do not protect
o,PI completely from ACT-mediated dam age, despite many potential roles
for metals in the damaging mechanism. The small protection that is
afforded by the chelators is probably related only to the inhibition of
production, or the degradation of, hydrogen peroxide.

xv

CHAPTER 1

INTRODUCTION

Inhalation of smoke from smoldering plant m atter has been practiced
for centuries. Tobacco is the plant most commonly associated with
smoking, although a host of plant materials have been and continue to be
smoked. During his voyages to the New World, Christopher Columbus
observed the native Americans indulging in the modern-day habits of
smoking and chewing tobacco. The use of tobacco becam e popular in
Europe in the 16th century, aided by the promotional efforts of Sir Walter
Raleigh. Also during this time, Seville in Spain becam e a center for an early
tobacco industry, where quality cigars w ere produced. It w as probably in
Seville th a t the name "cigarette" first originated from the use of cigar
scraps to make a poor m an 's substitute for relatively expensive cigars.
However, the modern concept of a cigarette as tobacco rolled up in paper
probably started in Central America, subsequently spreading to the
S outhw est United S tates in the early 1800s. During the 19th century the
popularity of cigarettes grew, and the invention of the first cigarettemaking machine in 1881 by Ja m es Bonsack of Virginia meant th a t the
cigarette industry could develop into the multi-million dollar industry it is
today. The profits to be reaped from tobacco w ere recognized by the
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British Crown during the 17th and 18th centuries. The resulting erosion of
to bacco grow ers' profits in the Americas, by the declaration that tobacco
w as a royal monopoly, undoubtedly contributed to the ultimate loss of
Britain's American colonies in 1776. The financial benefits gained by
industry and governm ent from the use of tobacco, however, have been
outw eighed by the detrimental health effects suffered by many tobacco
consum ers. The harmful effects of tobacco use are the basis for the
studies in this dissertation.

1.1 The Physical and Chemical Nature of Cigarette Smoke.
Throughout this dissertation, the term s "smoke" and "cigarette
smoke" refer exclusively to smoke derived from burning tobacco. Cigarette
sm oke is a dynamic system com posed of an electrically neutral aerosol of
liquid particles suspended in a mixture of primarily atm ospheric gases. The
average diameter of the particles in fresh smoke is about 0 .1 5 - 0 .1 6 jjm.
After 1 s of aging the diameter of the particles can be as large as 0 .4 ym,
due to particle coalescence (1,2). Smoke, with its particle concentration of
approximately 1.3 x 1 0 1o/cm3 (3), is a highly concentrated aerosol, more so
than many other types of environmental pollutant. Since the average
cigarette "puff volume" is 35 c m 3, a smoker inhales about 4 .6 x 1 011
particles per puff.

3

h 1,1 Sidestream smoke.
Sidestream smoke is the smoke that issues from the smoldering coal
end of the cigarette. Numerous com ponents of m ainstream smoke, many
of which are toxic, are present at substantially greater concentrations In
sidestream smoke (4). Thus, passive sm okers also are exposed to a
significant burden of toxicants by inhalation of environmental tobacco
sm oke (4).
f. f'2 Mainstream sm oke.
Mainstream cigarette smoke exits from the butt-end of a cigarette as
air is draw n over the firecone during puffing. The enormous complexity of
com pounds in cigarette smoke results from a combination of distillation,
pyrolysis and combustion of tobacco material at tem peratures up to 9 0 0 °C
in an oxygen deficient, hydrogen rich atm osphere. Dube and Green (3)
have presented data showing that there are 3 8 0 0 identified com pounds in
tobacco smoke. The m ost studied portion of cigarette smoke (gas and
particulate phases) comprises < 20% w /w of the whole smoke, the rest is
nitrogen, oxygen and carbon dioxide (3,5).
In many cases both mainstream and sidestream sm oke are
subdivided into gas and particulate phases for both chemical analyses and
biological studies. The gas (or vapor) phase of cigarette sm oke is defined
as that portion of the cigarette smoke th a t passes through a glass fiber
filter rated to remove 9 9 .9 % of all particles a: 0.1 /ym in diameter, i.e., a
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Cambridge filter (6). The smoke phase collected on the filter is the
particulate phase. Also, a "semivolatile p h a se ” has been proposed by
Williamson e t a/. (7), which is com posed of material th a t is volatilized at
180-190 °C from particulate matter on a Cambridge filter.
The Cambridge filter is probably the most widely used device for
collecting cigarette smoke com ponents. Cambridge filters effectively
sep arate the g as phase from the particulate phase com ponents, but there
are com ponents common to both phases. Components of th e gas phase
th a t are hydrophilic can deposit on the filter as it becom es w etted with the
collection of particulate matter (6). Generally, the collection of cigarette
smoke on a Cambridge filter at room tem perature does not result in the
formation of artifacts (3). However, artifacts arise as a necessary
co nsequence of the aging of smoke and these could be important in a
biological context. Such artifacts have been of particular interest to the
Pryor research group, as is evident from the results presented in this
dissertation and earlier work (8-11).
/■ 1.3 Gas ph ase smoke.
Table 1 show s som e of the major classes of com pounds in gas
phase cigarette smoke along with the approximate quantity of the largest
representative. Some of the com pounds which are of interest from the
point of view of smoke toxicology are also noted.
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Table 1.

Major com ponents of g as phase cigarette smoke*.

C lass

Largest Representative, i/o/cia.

Various C com pounds

Carbon monoxide, 1 0 0 0 0 -2 3 0 0 0

Various N com pounds

Nitric oxide, 5 0 -6 0 0
Ammonia, 50 -1 7 0
Nitrosamines, 0 .0 0 0 5 -0 .2

Alkanes

Methane, 8 0 0

Alkenes

Isoprene, 4 0 0

Alkynes

Acetylene, 25

Aromatic Hydrocarbons

Toluene, 8 0
Benzene, 20-50

Halogenated Hydrocarbons

Methyl chloride, 160
Vinyl chloride, 0 .0 0 1 3 -0 .0 1 6

Alcohols

Methanol, 180

Aldehydes

Acetaldehyde, 5 00 -1 2 0 0
Acrolein, 50-100
Formaldehyde, 50-100

Ketones

Acetone, 3 5 0

Nitriles

Hydrogen cyanide, 150-300
Acetonitrile, 140

a - Data from Refs 5 and 12.
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These include ciliatoxic a g e n ts,e.g. HCN, acrolein and acetaldehyde, and
carcinogens, e.g. benzene, formaldehyde and vinyl chloride.
h f ,4 Particulate Phase smoke.
There are distinctions betw een total particulate matter (TPM: the
abbreviations used throughout this dissertation are listed in Appendix A),
"tar" and condensate. The TPM is the particulate material collected on a
Cambridge fitter using the "puff-protocot" smoking method. The puffprotocol is based on patterns noted for smokers and is a standard method
of smoking cigarettes for analytical purposes. The protocol consists of
puffs of 35 ± 0 . 5 mL drawn over a period of 2 ± 0 .2 s at intervals of 60
± 1 s (13). "Tar" is defined by the Federal Trade Commission as the
weight of TPM minus the weight of w ater and nicotine (13). Cigarette
smoke con den sate is whole smoke collected in a low tem perature trap, or
bubbled through an aqueous buffer. The term "condensate" is frequently
used incorrectly in the literature to refer to TPM or tar.
The particulate phase is much more chemically complex than the gas
phase. Table 2 show s a typical composition for the major groups of
com pounds in the particulate phase. The particulate phase has been
studied closely with respect to its co-carcinogenic and carcinogenic
properties (discussed in section 1.2).
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Table 2.

Major groups of chemical compounds in the particulate phase

of cigarette smoke".

Class

Quantity, ma/cio.

H um ectants

3.0

Nicotine/nornicotine

1.6

Leaf pigment

1.5

Hydrocarbons

1.5

Carboxylic acids

1.2

W axes

1.12

Phenols

0 .6

Aldehydes

0 .5

Amides

0.1

Metals

0.1

Aliphatic amines

0 .0 6 5

Polyaromatic hydrocarbons

0 .0 0 5

Naphthalenes

0 .0 0 4

Nitro com pounds

0 .0 0 4

Nitrosamines

0.0001

a - Data from (5).
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7 .1.5 Free radical chem istry o f gas Phase and particulate ph ase cigarette
sm oke.
1.1.5.1

Gas ph ase sm oke. Early studies of the radicals in cigarette smoke

used electron spin resonance spectroscopy (ESRI at liquid oxygen
tem peratures (14). Spin trapping studies, indicating that alkoxyl radicals
are a major radical species in cigarette smoke, were performed as early as
1971 (15). The results from more thorough spin trapping studies of gas
phase sm oke radicals suggest that carbon centered radicals generated from
tobacco com bustion are the precursors for alkoxyl radicals (16-18). Also,
th e fact that the concentration of radicals increases as the smoke ages,
and that this closely parallels the formation of nitrogen dioxide, offers an
explanation for the apparent longevity of gas phase smoke radicals (17,18).
It has been suggested that nitrogen dioxide formation is related to a
steady-state production of radicals in gas phase sm oke (17,18).
The free radical chemistry of gas phase sm oke has been modelled
using a mixture of NO/air/isoprene (18,19). This gas phase sm oke model
produces both the carbon and oxygen centered radicals d etected in the
studies of authentic smoke and involves tw o other gas phase radicals,
namely nitric oxide and nitrogen dioxide. However, the m echanisms
proposed for the formation of the radicals in this model do not necessarily
exclude other mechanism s for radical production in gas phase smoke (19).
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Reactions pertinent to radical chemistry of g as ph ase smoke are show n in
equations 1 to 7 (17-19).
2 NO + 0 2 ------ > 2 N 0 3
\
/
N 0 2 + C=C ----------- >
^

\

(1)
I I
CLN-C-O
I I

(2)

R» + 0 2 -------- > R 02*

(3)

R 02» + NO ------ > RO* + N 0 2

(4)

R 02» + N 0 2 " . . .

(5)

R O + NO,

R02-N02

>RO-NO,

R* + NO, ------- > R-NO,

(6)
(7)

NO, = NO or N 0 2.
1.1.5.2

Particulate ph ase smoke. Studies in the late 1950s and early

1960s on the so-called "cigarette tar radical" suggested that it consisted of
an odd-etectron delocalized over a polynuclear aromatic hydrocarbon
structure (14,20). Later, in the early 1980s, Pryor and his coworkers
completely revised this previously unchallenged concept of the tar radical
(17,18,21). The studies reported by Pryor's group involve a direct
observation of the radicals by ESR and su g gest that the principal "tar
radical” consists of hydroquinone/semiquinone/quinone units held in a
"tarry matrix" (18,21). Since cigarette smoke is rich in polyphenols it is
reasonable that semiquinones are present, either alone or as part of a
polymeric framework. Data from ESR and a series of chemical tests
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revealed that the tar radical contains mainly o-semiquinone groups and
shares similarities with melanin, another polymer rich in o-semiquinones.
The addition of base to alcoholic extracts of particulate phase smoke
results in the appearance of strong p-benzosemiquinone radical signals
(17). The relative abundance of hydroquinone in cigarette sm oke is
compatible with this observation.
Spin-trapping studies have been applied to aqueous buffer extracts
of the particulate phase (22). Three spin adducts resulting from hydroxyl,
alkyl and carbon dioxide radical anions are detectable, and their formation
is dependent on hydroxyl radical production in the extracts. The hydroxyl
radicals are thought to arise from metal-assisted decompositions of
hydrogen peroxide. The hydrogen peroxide in turn is generated by
autoxidation of polyphenols in the extracts (22-25). Thus, the
abundant polyphenols in cigarette smoke could be the ultimate source for
all the free radical species detected in the particulate phase.

1 l2 Cigarette Smoking as a Maior Health Threat.
A number of disease sta te s are causally related to tobacco smoking.
The three major pathological conditions associated with smoking are
cardiovascular disease, cancer and chronic obstructive pulmonary disease
(26). These are probably the major causes of morbidity and mortality in
the developed world (27). Smoking is also associated with retardation of

11

fetal growth, increased neonatal mortality, peptic ulcer disease and allergic
immune reactions (26). Non-smokers, due to passive smoking, are also at
risk to the possible detrimental health effects of environmental tobacco
smoke.
Cigarette smoke is thought to contribute to cardiovascular disease by
increasing carboxyhemoglobin levels in sm okers' blood (28). Chronic
exposure to carbon monoxide, at levels which are likely to be experienced
by smokers, cau ses arterial wall injury and alterations in lipid metabolism
leading to hypercholesterolemia (28). Chronic exposure to carbon
monoxide also leads to myocardial degeneration due to stress placed on the
heart as more blood is pumped to overcom e oxygen deficiency (28).
Free radicals in smoke, formed either directly or through aging of
smoke com ponents, have been proposed to be involved in som e
cardiovascular disease events. Smoke radicals may modify low density
lipoprotein and transform macrophages into lipid laden foam cells (29).
Also, smoke com ponents can alter the plasma antioxidant sta tu s to
increase lipid peroxidation which could then becom e an important risk
factor in the initial events of atherosclerotic plaque formation (30).
The relationship betw een tobacco smoking and cancer has been
appreciated for at least 4 0 years. The development of lung can cer is
known to be causally related to cigarette smoking; an increased incidence
of lung tumors correlates with smoke dosage (31). The advent of "lower

12

ta r ” cigarettes has reduced the incidence of smoking-related lung cancer,
however, th e frequency of lung cancer among smokers is still greater than
th a t observed for non-smokers (31). Cigarette smoking is also causally
related to oral cancer, cancer of the larynx, esophagus, bladder, kidney and
pancreas (31).
The carcinogenic activity of cigarette sm oke resides primarily in the
particulate phase. Most of the com pounds involved in the induction and
maintenance of malignancy are contained in the neutral portion of
particulate p hase material fractionated by a series of extractions using
acidic, neutral or basic solvents (12). The potent carcinogenic fractions
contain mainly polynuclear aromatic hydrocarbons, which sh o w tumor
initiation in skin te sts in the presence of co-carcinogenic fractions from the
particulate phase (12). The major co-carcinogen and phenolic com pound in
cigarette sm oke is catechol. Cigarette smoke also assists in th e metabolic
activation of some of th e se carcinogens by increasing aryl hydrocarbon
hydroxylase activities in the lung and other tissues (32).
Cigarette smoke contains organ-specific carcinogens, such as
primary amines (bladder carcinogens), thus explaining the ability of smoking
to induce cancers at sites other than the lung. The involvement of active
oxygen species in the carcinogenic/DNA damaging activity of cigarette
smoke has been proposed on the basis of studies in vitro and in vivo
(25,33-36).
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1.3 The Pulmonary Absorption and Deposition of Cigarette
Smoke.
The deposition and clearance of cigarette sm oke material in the lung
is of prime importance with regard to its toxicity. Many of the volatile,
water-soluble com ponents of cigarette smoke (i.e. , gas phase com ponents)
are absorbed in the oropharyngeal region of the respiratory tract (37).
However, this does not mean that gas phase smoke has no role in
pulmonary injury (38,39).
Particle size is the major determinant of deposition patterns in the
lung. Since cigarette smoke particulates are small and have low volatility
they can penetrate deep into the pulmonary region of the respiratory tract
(40-43). The three major mechanisms for particulate deposition, viz.,
sedimentation, diffusion and inertial impaction, operate in the pulmonary
region. Impaction is the primary deposition mechanism in the
nasopharyngeal and tracheobronchial region. The sites of development of
bronchocarcinoma and smoking induced em physem a are located at
bifurcations of the terminal bronchioles (44-46), which are also the primary
sites for the deposition of cigarette smoke particulates (44-46).
Different mechanisms for the clearance of foreign material from the
lungs operate depending on the region of the respiratory tract involved.
The particulate burden to distal parts of the lung is increased during
cigarette smoking since the protective m echanisms in the nasopharyngeal
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region (nose hairs and impaction in nasal mucus) are bypassed. However,
particles can impact in mucus in the oropharyngeal and tracheobronchial
regions. The m ucus lining forms part of a "mucociliary escalator", in which
the m ucus is propelled upward along with entrapped particles to the
oropharyngeal region where the mucus is removed by expectoration and
swallowing.
Approximately 30-40% of cigarette sm oke particulate matter is
deposited in the alveolar region where the mucociliary escalator does not
function (40). Alveolar clearance involves dissolution of the particles and
engulfment by alveolar m acrophages (AM), which then exit the lungs via
the mucociliary escalator. Unfortunately, particulate clearance mechanisms
are impaired in chronic smokers, thus exacerbating the toxic effects of
cigarette smoke (40,47).

1 A Protein Inhibitors of Proteinases.
There are at least four ways of controlling extracellular proteolysis in
vivo: a) regulation of proteinase synthesis; b) control of proteinase release;
c) zymogen activation; d) inhibition by antiproteinases. Antiproteinases, a
class of protein found in plants, animals and microorganisms, function as
protein inhibitors of proteolysis. By presenting a scissile peptide bond in an
idealized structural environment, an antiproteinase can prevent a proteinase
from hydrolyzing its normal substrate. Although the exact function of
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som e antiproteinases is uncertain this is not the ca se for mammalian blood
plasma antiproteinases which constitute about 10% of the total plasma
protein (48).
L.4 , 1 A loha-1-proteinase inhibitor and the Semins.
There are several families of antiproteinase which are categorized
according to the mechanistic class of proteinase they inhibit. One family of
proteinase inhibitors is called the serpin (serine proteinase inhibitor)
superfamily (49,50). Members of the serpin superfamily have common
functional domains and tertiary structural features; they are single chain
glycoproteins stabilized by internal Glu—Lys salt bridges and form 1:1
com plexes with their targets (51). One of the most familiar serpins is
bovine pancreatic trypsin inhibitor (BPTI, Kunitz inhibitor), a favorite subject
of protein biophysical studies.
The susceptible peptide bond directed toward the proteinase target is
termed the "reactive site" (52). By convention, the reactive site residues
are numbered leading aw ay from the scissile bond so that P, and P',
correspond to the first residues in the N- and C- terminal directions,
respectively (53). The specificity of the inhibitor is determined by the
nature of the P, residue, e.g. if P, is Arg or Lys, then the inhibitor is an
antitrypsin, however if P, is Tyr or Phe, then the protein is an
antichy motry psin.
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The kinetic param eter most commonly used to describe proteinaseantiproteinase interactions is the association rate co n stan t (kMOC), which
has values measuring less than the diffusion controlled rate. The higher
the k_.ec for a particular proteinase the more likely th a t proteinase is to be a
physiological target (54). The corresponding dissociation rate con stant
(kdi«Dc) f ° r decomposition of the proteinase-antiproteinase complex is
usually very low (< lO ^ .s'1) for effective inhibitors. Another parameter,
applied to the in vivo situation, is the delay time of inhibition [d(t)L i.e., the
(> 97% ) time required for a given am ount of antiproteinase to completely
inhibit an equivalent am ount of proteinase (54). Calculation of d(t) is
dependent on knowledge of the k_#oc and of the physiological concentration
of the antiproteinase. So, for an antiproteinase to be an effective inhibitor,
reaction with the target must be fast and essentially irreversible (54).
Alpha-1-proteinase inhibitor (o,PI), also known as alpha-1-antitrypsin,
is the major serum antiproteinase in humans; it also acts as an
antiproteinase in various tissues, notably in the lung (48). The
antiproteinase function of o,PI w as first detected by its ability to inhibit
trypsin. However, neutrophil elastase (NE) is the primary target for a,PI;
the k_.cc value for o,PI interaction with human NE is 6.5 x 107 M '. s '1 (55).
Alpha,PI has been a subject of intensive investigation, partly because it is
the major serum antiproteinase and also because the genetically determined
deficiencies of a,PI are associated with a number of diseases.
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1.4.1.1

Alpha,PI protein structure and biosynthesis. Figure 1 is a

schem atic representation of the major structural features of a,PI. Alpha^PI
is a single glycosylated polypeptide chain with 3 9 4 smino acids and has a
molecular weight of 52 ± 1 kDa (51). Alpha,PI contains no intrachain
disulfide bonds, but has a single cysteinyl residue which exists as a free
thiol or in a disulfide linkage with cysteine or glutathione (56). The folded
protein is globular with dimensions of 6.7 x 3.2 nm; N-linked carbohydrate
chains are located externally at one end of the molecule with the reactive
site at the other end (57). The carbohydrate chains have a common core
composition, with "antennae" of identical composition attach ed to this core
to give to bi- or tri-antennary structures (48,58,59). The carbohydrate
composition of o^PI varies depending on the isoform of o,PI (51). The
folded molecule contains 30% o-helix (9 o-helices) and 4 0% /?-sheet (3 £pleated sheets) (57). There are tw o intramolecular salt bridges, both of
which stabilize the protein structure and are involved in the com mon
deficiency mutations (57). The N-terminal residue is glutamate and the Cterminal residue is lysine (48). Alpha,PI is negatively charged at
physiological pH (pi ca. 4.5). Also, Lys and Arg residues are concentrated
at the reactive site end of a,PI and the acidic residues and carbohydrate
chains at the opposite end, thus the molecule p o ssess a notable dipole
moment (57).

CHO

Reactive Site
394

Figure 1. A schematic diagram of the major structural elements of the
human c^PI protein, f i , o-helix; % ( 0-sheet; CHO, carbohydrate;
, salt bridge. (Reproduced and modified from Ref. 60 with permission of
the American Society for Clinical Investigation).
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The reactive site sequence is show n below (61), with the susceptible
peptide bond (Met368—Ser360) presented to the target as part of an exposed
loop:

p*

p3

P2

P,

P'i

P'z

P'a

P'*

Ala

lie

Pro

Met360

Ser360

lie

Pro

Pro

This reactive site loop structure places the native a, PI molecule in a
stressed conformation, as show n by a 6.7 nm separation betw een Met368
and Ser350 in reactive site cleaved o,PI (57). The presence of a
hydroxylated amino acid at P', in a,PI is characteristic of serpins,
suggesting an important function (50). The P', residue is not directly
involved in interaction of the serpin with the target proteinase
but ensures correct folding of the antiproteinase into the conformationally
active state (62).
There are approximately 75 known normal alleles of the a,PI gene
(60), and within the general population there are at least tw enty isoforms
of a,PI (48). Classification of these forms is based on electrophoretic
mobility, a system called the "Pi system ". The com m onest genotype of
a,PI is PiM and so P i ^ represents the normal homozygous phenotype (48).
In addition to the genetic diversity, the serum of a PiMM individual contains
five isoforms of o,PI due to post-translational modifications (63). These
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five isoforms arise due to differing structural arrangem ents of the three
carbohydrate side-chains and differing polypeptide chain length (63). The
carbohydrate side-chains play no role in the proteinase inhibitory action of
a, PI, but their removal increases the thermal lability of the protein,
diminishes excretion of a,PI by cells and reduces the plasma half-life of the
protein (64-66).
A lp h a ^ l is synthesized primarily in the hepatocytes (48,63); this
synthesis in turn regulates the serum levels of a,PI and hence of the lung
(63). Neutrophils (PMN) and m acrophages synthesize small am ounts of
a,PI (51). Despite the importance of a,PI and its substantial increase in
concentration in the serum during systemic inflammatory responses, the
m echanism s involved in controlling up-regulation of the a,PI gene are
unknown (51).
1.4. 1.2 Alpha}Pi inhibitory mechanism. The generally accepted
mechanism of action of antiproteinases is as follows:
e

+ i ; = = : ei —

c

; = = ± : e i’ -

—

e

+

r

(8)

w here, E is the proteinase target; I is the antiproteinase; C is a staole
proteinase-antiproteinase complex and I' is the cleaved antiproteinase (52).
In "C" the P r P ', bond is intact, although the carbonyl group of the scissile
peptide bond sho w s some tetrahedral character (52,67). This tetrahedral
distortion is induced by interaction of the reactive site with the oxyanion
hole and the Or of the proteinase active site seryl residue (52).
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Members of the a, PI family have an inhibitory mechanism different
from other serpins in that the cleaved antiproteinase is unable to combine
with the proteinase (48,68,69):
k 1

E + I

^2

El
k.T

^3

^

C

^4

^ El*----------- > E + I*

(9)

k.2

The k_TCr is always less than expected for a diffusion controlled
process, suggesting that the inhibition reaction is more complex than a
simple bimolecular encounter (70). A proposed reaction profile for serpinproteinase interaction shows docking of the tw o partners is a tw o-step
process to give the stable El complex (C) lying in a deeper free energy
trough com pared to the corresponding proteinase-substrate complex (68).
Consequently, the free energy of activation required for hydrolysis of the
reactive site peptide bond is large, and thus a "good” inhibitor is not
cleaved. The structural elements of the reactive site loop that make o,PI
an inhibitor and not just a good substrate are still unknown. Since k , and
k 2 in equation 9 have finite rates, OtPI is strictly a reversible inhibitor. But
the values of k., and k 2 are so low that c^PI is usually termed a "pseudoirreversible inhibitor" (68,71,72). In a physiological context the back
reactions are of no importance since proteinase-antiproteinase complexes
are cleared much faster from the circulation than the rate of complex
dissociation (68).
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The complex betw een or1PJ and its target proteinase is stable enough
to imply a covalent linkage betw een the tw o, although a complex
containing an acyl-enzyme intermediate or a "relaxed” inhibitor is
considered unlikely (68,69). Usually NE remains attached to o^PI in a
highly stable complex (48). Cleavage of the reactive site peptide bond of
a,PI yields a 4 7 .8 kDa N-terminal fragment and a 36 residue, 4 .2 kDa Cterminal fragment that remains tenaciously bound to th e larger fragment
under physiological conditions (48). A number of human serpins modified
by reactive site cleavage exhibit conformational chan ges resulting in a large
increase in conformational stability (73). The increased stability of o^PI
after cleavage may be due to the completion of a 5 strand £-sheet using
the reorganized reactive site loop in the cleaved inhibitor (57,69,74).
Smaller proteinase inhibitors, such as BPTI, can undergo reactive site
cleavage, but this leads to a destabilization of the tertiary structure (73).
T hese smaller inhibitors can also undergo reactive site peptide bond
resynthesis by proteinases (73).

A comparison of the solution structure of

the native and cleaved forms of a,PI sho w s no evidence of gross "global”
conformational changes (74). Thus, the local ch ang es induced by cleavage
result in relatively minor gross structural changes in the c^PI.
The cleavage of serpins is accompanied by a complete loss of
inhibitory activity and such cleavage in vivo usually arises from abortive
interactions with proteinases. The reactive site peptide bond in a,PI is also
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susceptible to cleavage by proteinases that are not inhibited by a,PI (48).
This proteolytic action may be a physiological mechanism to control
proteolytic activity by inactivating the inhibitor.
1 .4 .1 .3

The catabolism o f a,Pl-proteinase com plexes. Uncomplexed or,PI

has a plasma half-life in humans of 4-5 days (60). The unglycosylated or
asialoglycoprotein has a som ew hat shorter half-life, measured in terms of a
few hours (60,65).
Serpin-proteinase complexes are cleared from the circulation via
receptors on hepatocytes (75,76). This clearance is independent of the
identity of the serpin (76,77). Structural features of the serpin revealed
due to conformational changes induced by interaction with the proteinase
target are probably the basis for recognition of serpin-proteinase complexes
by receptors (77,78),
The o,PI-NE complex and reactive site cleaved-t^PI are not
biologically inert entities destined simply to be degraded. There are
receptors for the a,PI-NE complex on AM and other cells. These receptors
not only serve as a binding site for catabolism of th e com plexes but may
also be associated with signal transduction m echanism s for increasing the
expression of the a, PI gene (79). The cell surface receptor recognizes a
pentapeptide sequence which is revealed w hen o,PI forms a complex with
the target or w hen o^PI is proteolytically modified (80,81). While the
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native <7,PI inhibits PMN migration (82), or,PI-NE complexes and reactive
site-cleaved-OfPI are chem otactic agents for PMN (83,841.

U i Luno Proteinases. Antiproteinases and Connective Tissues.
1,5,1 Antiproteinases.
Alpha,PI is present at simitar concentrations in epithelial lining fluid
(ELF) throughout the lung, and constitutes > 90% of the anti-NE activity in
the ELF of the lower respiratory tract (51,85,861. The highest
concentration of a,PI is detected in the blood plasma. The concentrations
in th e alveolar interstitial spaces and alveolar ELF are about 5 0-70% and
10% , respectively, of the plasma concentration (51). Although a,PI
represents the major lung antiproteinase, there are other antiproteinases
present. Table 3 provides details of the major antiproteinases relevant to
the lung.
1,5-2 Proteinases.
Neutrophils and AM are the major sources of lung extracellular
proteinases. These proteinases are generally of the serine- and
metalloproteinase mechanistic class (87). The PMN are undoubtedly the
major source of lung extracellular proteinases, capable of releasing NE,
cathepsin G, collagenase and gelatinase (87-91). All of the PMN
proteinases are stored in an inactive form in three types of granule within
the PMN cytoplasm (87). Release of the proteinases into the extracellular
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Table 3.

Major antiproteinases relevant to the lung*.

Antiproteinase

MW

Proteinase

Plasma

ELFfc conc.

(kDa)

Target

conc. (/sM)

{//M}

C r,P I

52

NE, Cathepsin G

2 0 -5 3

2

SLPI

12

NE, Cathepsin G

0 .00 4-

1.0

-

-

6
1.2

0 .0 0 7
o^AChy

68

Cathepsin G

6

TIMP

29

Coliagenases

0 .0 3

-

8

0 .5 - 1.0
?

Stromelysins
7 20

All classes of

2.5 - 5.0

0.01

proteinase

a - Reproduced and modified with permission from Ref. 51.
b - Abbreviations: o^AChy, alpha-1 -antichymotrypsin; o3M, alpha-2macroglobulin; ELF, epithelial lining fluid; NE, neutrophil elastase; SLPI,
secretory leukoproteinase inhibitor; TIMP, tissue inhibitor of
metalloproteinases.

26

medium takes place by three main modes: a) leakage from phagocytic
vacuoles during particle engulfment; b) degranulation in response to an
inflammatory stimulus, and c) cell death (87).
Neutrophil elastase is the most important proteinase both with
regard to c^PI and the destruction of the lung connective tissue matrix
during pathological conditions (87). However, NE is essential for the
antimicrobial function of PMN. The NE content of human PMN varies
betw een individuals. Individuals with genetically determined higher levels
of NE in the PMN are at a greater risk for developing lung disorders such as
em physem a (92,93).
Human neutrophil elastase (HNE) is a cationic, globular, 3 0 kDa
glycoprotein consisting of a single polypeptide chain with 2 2 0 amino acid
residues, four disulfide bridges and tw o Asn-linked carbohydrate chains
(91,94-96). Human NE derives its name from its ability to digest elastin,
but it will hydrolyze appropriate peptide bonds exposed on other
extracellular proteins (87). The substrate binding pocket of HNE is
hemispherical, relatively hydrophobic and constricted at the base by bulky
residues (96). The binding pocket is suited to accom m odate residues with
small aliphatic side chains: HNE preferentially hydrolyses peptide bonds
with Val in the P, position (91). Elastin is abundant in residues such as Ala
and Val (96). The HNE substrate binding site can also interact with, and
hydrolyze, peptide bonds with Met in the P, position, e.g. Met368 of a,PI
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(91). However, oxidation of Met368 in o,PI to the sulfoxide results in severe
steric hinderance to binding (96), which explains th e 2000-fold d ecrease in
f ° r HNE interaction with native ff,PI vs. a,PI containing methionine
sulfoxide at position 35 8 (MetSO358) (55,72,91). Alpha,PI containing
MetSO368 is much poorer at inhibiting elastolysis than is the native inhibitor
(72). Also, the HNE-o,PI complex formed from a,PI containing MetSO358 is
less stable than that formed from native o,PI (71,72).
The mechanism of catalysis by HNE typifies that of the serine
proteinases with regard to the so-calted "catalytic triad" of Ser, His and
Asp (96). The His residue acts as a proton acceptor from the nucleophilic
Ser in the active site, and development of positive charge on His is
stabilized by the Asp (97). The development of negative charge on the
carbonyl oxygen of the scissile peptide bond during nucleophilic attack of
Ser-Or is stabilized by hydrogen bonding interactions with main chain -NH
groups in the "oxyanion hole" (97).
Alveolar m acrophages are also a source of cathepsins and various
metalloproteinases. Although elastinolytic activity in vitro has recently
been described for AM, their role in extracellular proteolysis is poorly
defined as compared to PMN (87,98-101).
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1-5.3 Connective tissues.
The pulmonary interstitium is that region of lung tissue that lies
b etw een the lung epithelial cell layer and the endothelial cell layer of the
capillaries. The pulmonary interstitium is com posed of basem ent
m em branes associated with the respective epi- and endothelial cell layers
and also various cell types and a continuous fibrous protein network. The
structural integrity of the interstitium is provided by several connective
tissue matrix com ponents, the major elements being collagen, elastic fibers,
fibronectin, proteoglycans and basem ent membranes. AM of the various
connective tissue com ponents are integrated into a large structure
encom passing the lung. This integrated structure is dynamic since many of
the com ponents are continually synthesized and degraded.
1 .5.3.1

Eiastic fibers. [The information concerning elastic fibers is derived

from Ref. 102]. Elastic fibers are present in most organs of the body,
w here reversible extensibility or deformability are required, particularly the
lungs and arteries. These fibers are com posed of tw o structural elements;
elastin and microfibrils. Elastin is an insoluble, hydrophobic, cross-linked
macromolecule which forms a three-dimensional network and gives elastic
fibers their elastic recoil properties. The microfibrils consist of highly
glycosylated proteins. Microfibrils act a s nucleation sites for the
development of elastic fibers; elastin synthesis is at its most intense during
the late fetat/early postnatal stag es of development, resulting in lifelong
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elastin deposition patterns that are complete by the end of the first decade
of life. Since most of the elastic fiber framework is established early in the
development of the lung, and because minimal elastin synthesis occurs in
adult lung, destruction of elastic fibers is essentially an irreversible process.
Tropoelastin, the monomeric precursor of functional elastin, is
synthesized in myofibroblasts as a 70 kDa protein which is secreted and
readily incorporated, under cellular guidance, into growing elastic fibers.
Tropoelastin consists of alternating hydrophobic and cross-linking domains,
and extensive intra- and intermolecular cross-linking of tropoelastin
molecules yields mature elastin. Cross-linking is initiated by oxidation of
selected Lys residues to aldehydes (allysine), catalyzed by lysyl oxidase.
Cross-links are formed in three main ways: a| aldol coupling of tw o
allysines; b) Schiff's base formation betw een Lys and allysine followed by
reduction to tysinorleucine; c) desmosine formation from the reaction of
four Lys side-chains. Elastin is also rich in Gly and there is a high
proportion of small chain aliphatic amino acids such as Ala, Val, Leu and
lie. W hereas tropoelastin is sensitive to proteolytic degradation before
incorporation into the elastin macromolecular structure, mature elastin is
very stable.
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1 l£ g,PL Emphysem a and Cigarette Smoking.
Emphysema is a chronic lung disease that is characterized by
abnormal and perm anent enlargement of the respiratory regions of the lung
distal to the terminal bronchioles (46,103). This enlargem ent is frequently
accom panied by connective tissue destruction (46,103). There are tw o
major forms of em physema: a) panacinar em physem a, which develops
uniformly throughout alveoli in the distal part of the acinus; b) centriacinar
em physem a, which is confined to the central region of the acinus (46,103).
Centriacinar em physem a is the more commonly observed form of the
disease, and is associated with cigarette smoking (4 6,10 4,10 5 ).
Emphysema develops as a result of excessive proteinase burden to
the alveolar interstitium (106-109). The proteinases are derived primarily
from PMN, although AM could also play a role (100,106). Individuals with
an inherited deficiency of plasma o,PI are at greater risk for developing
em physem a, thus o,PI function is suggested to be intimately associated
with the pathogenesis of the disease (110). Also, since the function of
o,PI is to inhibit NE, then NE is probably the major destructive proteinase in
em physem a. Support for the involvement of proteinases in em physem a is
provided by the detection of em physem atous lesions in the lungs of
experimental animals after intratracheal instillation of proteinases, such as
porcine pancreatic elastase and NE (46,106). These various observations
are unified in a common concept known as th e "proteinase-antiproteinase
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theory of em physem a", which proposes that em physem a develops as a
result of unrestricted proteolytic activity in the lower respiratory tract
(108,109,1111. This theory explains the pathogenesis of em physem a
resulting from cigarette smoking or inherited deficiencies of c^PI.
1<6,1 Inherited em physema.
In order for em physem a to develop, th e levels of circulating o,PI
need to be below a critical level (60). Normal serum o,PI concentrations
can lie betw een 20 and 53 //M; concentrations below 11 /sM place an
individual in the "at risk" category for the development of em physem a (60).
There are tw o common inherited o,PI variants that can place a person at
such a risk, th e se are the "Z" and "S" variants. Greater than 9 0 % of all
c a ses of serum o,PI deficiency are due to Z hom ozygotes, who have serum
a,PI concentrations in the range 3-7 //M; the SZ heterozygote is mildly at
risk in the 8-19 //M range (60,63,107). The protein derived from the Z
gene has a Lys substituted for Glu342, which results in the disruption of a
salt-bridge, and consequent incorrect protein folding (6 0 ,6 3 ,1 1 2 ,1 1 3 ).
Although the Z variant is synthesized normally, only about 15% of the
protein is secreted into the plasma (60,114). A co nsequ en ce of the poor
secretion of the Z variant is intrahepatocyte accumulation of the incorrectly
folded protein which can lead to liver disease in som e individuals
(6 0 ,6 3 ,1 1 2 ,1 1 3 ). The S variant has a Val substituted for Glu284, disrupting
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another salt-bridge, which leads to excessive intracellular degradation of
newly synthesized c^PI (60,63,113).
For the Z homozygote, em physem a manifests itself as a slow onset
of dyspnea appearing noticeably betw een ages 50-60; death due to
respiratory failure usually occurs by age 60-70 years (60 ,1 1 3,11 4). In the
c a se of Z hom ozygotes who smoke, the disease progression is usually
shifted 15-20 years earlier (60,114). However, there are many instances
of asym ptom atic individuals with inherited or acquired or,PI deficiencies
(60,108).
A variety of therapeutic strategies have been, and are being,
developed to enhance antiproteinase activity in the lower respiratory tract
of persons at risk for the development of em physem a (60). The more
successful approaches have involved administration of a,PI directly to the
lung in aerosol form (60). Also, a promising recent advance is the
introduction and expression of the o,PI gene in the lung epithelium of rats
(115).
1* 6 .2 Smokina-induced em physem a.
Emphysema is predominantly a smoking related disease, which
would be eliminated as a major public health problem if cigarette smoking
w as abandoned (46,105). A variety of factors are proposed to be involved
in the pathogenesis of smoking-induced em physem a, including decreased
antiproteinase activity in the lower respiratory tract of smokers (116).
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Oxidative dam age to a, PI has received the most attention as th e cau se for
th e depletion of antiproteinase activity in sm okers' lungs
(4 5 ,1 0 9 ,1 1 6 ,1 1 7 ), however, evidence that oxidative dam age to c^PI
occurs in vivo is sparse (118,119). Cigarette smoke and inflammatory cells
are the tw o main sources of oxidants that could dam age o^PI.
in vitro studies using r^PI exposed to "clean" oxidation system s,
such a s N-chlorosuccinimide, chloramine-T or myeloperoxidase/CI7H20 3
have show n that tw o methionyl residues (Met368 and Met361) are oxidized to
th e sulfoxides (120,121). Also, in vitro studies using activated PMN and
AM have show n that reactive oxygen species derived from th e se celt types
can dam age c^PI and the dam age is dependent on myeloperoxidase (MPO)
activity in th e case of PMN (122-126). in vivo studies have dem onstrated
that MPO can decrease antielastase activity in lung lining fluid (127), and
MPO activity is higher in PMN from sm okers' as compared to nonsm okers'
lungs (128).
Several studies using human plasma, lung fluid and purified a,PI
exposed to cigarette smoke have dem onstrated dam age to a , PI (129-136).
In som e of these reports, the dam age w as presumed to be oxidative,
perhaps involving free radical species (1 2 9 ,1 3 3 ,1 3 5 ,1 3 7 ,1 3 8 ), although,
non-oxidative dam age to o,PI by cigarette smoke is also probable
(131,138). The relative importance in vivo of oxidative dam age to o,PI by
cellular vs. cigarette smoke-derived oxidants is unknown at present.
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Methionine sulfoxide (MetSO) has been detected in cr,PI recovered
from healthy sm okers' lung fluids, with no significant chan g es in other
amino acids (119). The a,PI from sm okers' lungs contained 4 MetSO/o,PI,
and there w ere no changes in the molecular weight or electrophoretic
mobility of the protein (119). In a different study, a*PI from healthy
sm okers' lung fluids w as found to be present in th e native molecular
weight form (139). The a,PI had both normal and more cationic
electrophoretic mobility and no t^PI with reversible oxidative modification
w as detectable (139). In contrast,

0

|PI from the lung fluids of smokers

with em physem a has molecular weights suggestive of native, proteolyzed
and complexed forms of the inhibitor and these studies also implied
oxidized or,PI could be present (140).
The importance of oxidative dam age to methionyl residues,
particularly Met358, as a primary m echanism for loss of a,PI activity is
illustrated by tw o sets of data. Firstly, a Val358 a,PI m utant exposed to Nchlorosuccinimide, MPO, activated PMN and gas phase cigarette smoke is
resistant to loss of activity over relatively short exposure times (138).
Secondly, otPI exposed to "clean" oxidant system s such as hydrogen
peroxide, chloramine T or the MPO system can be reactivated by t reatm ent
with MetSO-containing peptide reductase (141,142). Methionine
sulfoxide-containing peptide reductase is a ubiquitous enzyme which
reduces peptide bound MetSO to Met using dithiothreitol or
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thioredoxin/thioredoxin reductase/NADPH (143). However, MetSOcontaining peptide reductase only partially reactivates a, PI exposed to
cigarette smoke in vitro, or o,PI recovered from sm okers' lungs (139,142).
It has been proposed that MetSO-containing-peptide reductase may be a
repair enzyme for MetSO366^ , ? ! in vivo, but this is questionable (142,144).
Unlike o,PI, HNE is less sensitive to oxidants such as chloramine-T, cellderived oxidants and smoke (1 24 ,14 5,14 6), such that antiproteinase
activity is expected to be decreased the most by oxidative/smoke
exposures in vivo (45).
Besides oxidative dam age, proteolytic inactivation of a,PI by
proteinases released from inflammatory cells could also play a role in
localized deficiencies in a-,PI activity (89,147-149). Metalloproteinases
released from PMN and AM, such as collagenase and gelatinase, are the
prime candidates for proteinases that could inactivate cr,PI (89,147-151).
Both oxidative and proteolytic damage to or, PI may play a role in the
localized depression of a,PI activity in lung connective tissue disorders such
as smoking induced em physema, but the relative importance of each
mechanism is unknown.
There are significantly increased numbers of AM and PMN in
sm okers' lungs (111,152-156). Also, the increased PMN population in
sm okers' lungs show s a longer residence time in the lung vasculature
(155,157). These observations have important implications for the
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proteinase-antiproteinase theory, since PMN and AM are vectors for
proteinases and oxidants (109,111).

Both the AM and PMN are likely to

have higher phagocytic activity, with consequent proteinase release and
generation of reactive oxygen species, due to the increased burden of
particulates in the lungs of smokers. The AM recovered from sm okers'
lungs are metabolically activated to produce greater am ounts of oxidants
com pared to those from nonsmokers' lungs (158-161). At least for PMN,
cellularly produced oxidants do not directly influence elastin degradation;
the proteinases are the primary degradative agents (162).
Various, equally valid, mechanisms have been proposed for the
increased content of PMN in sm okers' lungs. Cigarette smoke stimulates
AM to secrete PMN chemotaxins, such as leukotriene B4 and interleukin-8
(163). Additionally, complement com ponent C3 is modified by cigarette
smoke in vitro: studies in vivo indicate that the alternative complement
pathw ay is activated in the lung after smoke exposure, liberating the C5a
fragment of complement com ponent C5, which is highly chem otactic for
PMN (164-167). Additionally, some cigarette smoke com ponents are
chem oattractants, as are som e degradation products of elastin and collagen
(109,111).
Although most studies of smoking induced em physem a have
concentrated on factors related to elastin degradation, it is also probable
th a t smoking could hinder repair of dam aged elastic fibers (109,116). in
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vitro studies have show n that aqueous solutions of gas phase smoke inhibit
elastin cross-linking reactions by a substrate directed mechanism (168).
Also, it has been dem onstrated in vivo th a t activities of lysyl oxidase
increase after elastase-induced tissue injury (169), but in conjunction with
cigarette smoke such increases have not been observed (170). Thus,
cigarette smoke generally exacerbates the effects of elastase-induced
em physem a in experimental animals (171).
The validity of the proteinase-antiproteinase theory in vivo depends
on th e detection of decreased antielastase activity and/or increased
elastinolytic activity in the lungs of smokers. Numerous studies over the
years have been directed at this question and the results have aroused
much controversy (10 8,109,111). Some investigators find the activity of
a,PI in the lung fluid of smokers com pared to nonsmokers significantly
d ecreases (119,172), does not change (140,173-176), or increases (139).
In c a se s where o,PI activity does not change it has often been suggested
that increases in elastase activity are more important than d ec re ase s in the
activity of antielastases (175,176). The reasons for such variations in the
data can be attributed to differences in methodology and subject selection
b etw een research groups (139,177,178). Three recent studies
dem onstrate decreased antiproteinase (177,179) or o,PI (178) activity in
sm okers' lung lavage, supporting the proteinase-antiproteinase theory and
the role of oxidative processes in em physem a (177,178). Some
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investigators have dem onstrated an increase in th e activity of or, PI in
sm okers' as com pared to nonsm okers' plasma, which probably results from
an inflammatory response due to chronic smoke inhalation (180,181).
Other studies on the elastolytic activity of lung fluids dem onstrate that
activity is increased in sm okers' lung fluid, mainly as a result of chronic
exposure to smoke (1 76 ,18 2,18 3). Also, NE has been d etected in close
association with elastic fibers in em physem atous lung tissues (184). Since
PMN from sm okers' lungs display no increased propensity to release NE
upon stimulation, the observed increases in elastolytic activity in sm okers'
lung fluid arise from the simple increase in the number of PMN (185).
The issue of decreased o,PI activity in sm okers' lungs is debatable,
and the controversy is difficult to solve with available lung lavage
procedures. The lavage m ethods currently used result in mixing of protein
populations from different lung microenvironments. Also, the sampling of
lung ELF is probably a poor m easure of o,PI and/or elastolytic activity in the
lung com partm ent of primary interest to em physem a, i.e. the interstitium.
This dissertation is concerned with the in vitro interaction of water
soluble com ponents of cigarette smoke particulate phase with a,PI. The
studies are aimed at examining som e basic features of the damaging
system and formulating a mechanism for the dam age to o,PI. Prior to
these studies, there have been several reports in the literature dealing with
this aspect of cigarette smoke research. Pryor e t al. have studied the

39

interaction action of gas phase and sidestream cigarette smoke with a, PI in
aqueous buffer (1 2 9 ,1 3 0,18 6-1 8 8). Additionally, several studies have
dealt with the effects of whole cigarette smoke, prepared in aqueous
buffers (133,135-137) or dimethyl sulfoxide (132,134), on o,PI activity.
Particulate phase material p er se has not been studied in any depth, unlike
the gas phase. Some of the earlier studies implied th a t dam age to o,PI w as
oxidative, but no direct evidence for this has been presented.
The studies in this dissertation complement som e of the studies
previously presented by Pryor e t a/, concerning the effects of gas phase
cigarette smoke on or,PI and particulate phase com ponents on DNA
(3 3 ,3 4 ,1 2 9 ,1 3 0 ). It is hoped that the results presented in this dissertation
will support some, and modify other, existing ideas concerning th e effects
of cigarette smoke com ponents on biomolecules, particularly <7, PI. Some
speculations about the in vivo situation can be made from the data,
although further experimentation is necessary to determine the relative
importance of cigarette smoke vs. cellularly derived species as effective
o,PI damaging agents.

CHAPTER 2

BASIC FEATURES OF THE AQUEOUS CIGARETTE TAR EXTRACT SYSTEM
AND THE DETERMINATION OF a,PI ACTIVITY.

2A . Basic Features of the Aqueous Cigarette Tar Extract System .
Many of the studies of cigarette smoke dam age to a, PI in vitro have
been done using organic solvent extracts of whole sm oke or cigarette
smoke condensate. W hereas tar is essentially com posed of particulate
phase com ponents, the condensate contains both particulate and gas
phase com ponents. Com ponents of the TPM that are extractable by an
aqueous buffer are studied in this dissertation and this is not th e sam e as
whole smoke bubbled through an aqueous buffer. The fractionation of
cigarette smoke into gas and particulate phases is probably the crudest
fractionation procedure, and has been used traditionally to simplify the
examination of the chemistry and biological effects of smoke. This type of
fractionation necessarily neglects effects arising from interaction betw een
com ponents of the tw o phases. Obviously, from a biological perspective,
an aqueous extraction is more realistic than an organic solvent extraction.
The w ater extractable gas phase and particulate phase com ponents have
differing chemistries and probably dam age a,PI by different mechanism s, as
will be evident from som e of the data presented in this dissertation.
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2. U 1 Experimental.
2 . 1. 1. 1 Preparation o f ACT. Research cigarettes w ere purchased from the
University of Kentucky Tobacco and Health Research Institute. The
cigarettes w ere stored at -10 °C and before use they were conditioned over
saturated aqueous ammonium nitrate at - 2 2 °C ( - 6 0 % relative humidity)
for at least 2 4 h (A. Vaught, University of Kentucky T obacco & Health
Research Institute, personal communication, 1982). The 1R1 reference
research cigarette w as used for most of the studies. The 2R1F cigarette, a
filter-tipped version of the 2R1 (a reference cigarette equivalent to the 1R1,
but manufactured in 1974 rather than 1969) w as also used. Some
characteristics of the 1R1 and 2R1F cigarettes are show n in Table 4.
Cigarette smoke particulate matter w as collected on a Cambridge
filter (No. CM-113; Cambridge Filter Corp., Syracuse, NY) from tw o 1R1
cigarettes, smoked dow n to a 23 mm butt length. Smoking w a s done
using the "puff protocol" (13), Smoke w as drawn by hand through the
Cambridge filter supported in a holder into a 50 mL glass syringe connected
to a three-w ay stopcock. Gas phase smoke w as expelled to th e air. The
Cambridge filter with adsorbed particulate matter w as extracted
for 3 0 min at 37 °C with 5 mL of incubation buffer. The extract w as then
filtered to remove fibers coming from Cambridge filter, yielding undiluted
ACT. The ACT from filter tipped cigarettes w as prepared in the sam e
manner, except the filter tipped cigarettes w ere smoked to dow n to 3 mm
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Table 4.

Characteristics of research cigarettes used In this study".

Cigarette

TPM

FTCb Tar

Nicotine

mg/cig.

mg/cig.

mg/cig.

1R1

3 5 .4

30.1

1.48

2R1F

28.6

2 3 .4

1.74

a - Source, Ref 189.
b - Federal Trade Commission.

43

from the filter overwrap. The term "incubation buffer" is used throughout
the te x t to refer to Chelex*-100-treated 0.1 M sodium phosphate, pH 7.4.
Chelex*-100 chelating resin (200-400 mesh, sodium form; Bio-Rad
Laboratories, Richmond, CA) w as routinely used to deplete 0.1 M
phosphate, pH 7.4 of redox active transition metal ions. The buffer w as
continuously stirred with Chelex*-100 (2.5 g resin/L buffer) for at least 12
h. Adjustment of pH w as made w hen necessary, and stirring continued for
at least 3 h after each adjustment. Chelex*-100 w as removed by vacuum
filtration, and the pH w as always rechecked.
2. 1. 1.2 The estimation o f water soluble particulate m atter in ACT. Pre
weighed vials were filled with 1 mL of either undiluted ACT or a control
solution consisting of an extract from a Cambridge filter not exposed to
sm oke. The solutions were lyophilized to remove volatile ACT
com ponents. It w as assum ed that volatile com ponents were removed to
an equal extent from all of the vials. The weight of the residue from a non
smoke-exposed Cambridge filter w as subtracted from the weight of the
residue from the ACT. The material balance w as termed 'non-volatile ACT
com ponents'.
2 . 1. 1.3 The standard protocol for incubation o f a fPf with ACT. The ACT
prepared as above w as, in most cases, diluted by half in the incubations
with a,PI. This "half-diluted ACT" is referred to in the text as simply
"ACT". In a few cases, however, where it is felt more appropriate, the
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extent of dilution is specified as "% v/v ACT" (referring to the percentage
of ACT, original 5 mL solution, diluted in incubation buffer). Since the
actual weight of material in ACT w as difficult to a s s e s s accurately, % v/v
w as considered the m ost suitable way to express the concentration.
The text that follows details the typical incubation conditions, but
variations to the protocol are described at the appropriate places in the
text. Alpha,PI used in these studies w as from human serum or plasma
(purity > 9 5 % by SDS-PAGE; Calbiochem Corp., San Diego, CA). Stock
solutions of 2 5 0 pg/mL a,PI in incubation buffer were routinely used. The
stock solution of o,PI w as mixed with ACT (1:1, v/v) to give the standard
incubation concentrations. The total volume of the incubation w as 3 0 0 pL.
The incubations w ere performed in the dark, in 500 pL Eppendorf vials, at
37 °C for 24 h prior to determining elastase inhibitory capacity (EIC) (see
section 2.2).
2 .1 .1 .4 Time course for EIC loss o f a,PI ex po sed to A C T and g as phase
smoke. The control for this experiment consisted of 125 */g/mL o,PI
incubated in buffer alone. As a further control experiment, 125 pglmL o,PI
w as incubated with an aqueous extract of a Cambridge filter. Cambridge
filter either exposed or not exposed to 20 puffs of ambient air
w as extracted as described for a cigarette smoke exposed filter (section
2 . 1 . 1 . 1 ).
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The gas phase extracts (GPE) w ere prepared by bubbling smoke
from tw o 1R1 cigarettes, using the puff protocol, into a vial containing
0 .7 5 mL of incubation buffer maintained a t 3 7 °C. Immediately after
smoking, 0 .7 5 mL of a 250 //g/mL a,PI solution w as added to give a final
volume of 1.5 mL. This 1.5 mL w as incubated under standard conditions.
Aliquots of 2 0 pi. w ere removed periodically for the EIC assay. Control
incubations w ere prepared using 0 .7 5 mL of incubation buffer exposed to
20 puffs of ambient air by the puff protocol. This solution w as then
treated a s described for GPE.
Direct gas phase (DGP) exposure w as performed as follows; 1.5 mL
of a,Pi (125 //g/mL) at 37 °C w as exposed directly to th e gas phase smoke
from tw o 1R1 cigarettes smoked using the puff protocol. This 1.5 mL w as
then treated in the sam e way as noted for GPE. The control incubation
consisted of 1.5 mL of 125 pgfmL o,PI solution exposed directly to 20
puffs of ambient air via the puff protocol. The ACT from filter tipped 2R1F
research cigarettes w as also tested for its otPI damaging properties using
the incubation conditions described for the ACT from 1R1 cigarettes.
2 . 1.1.5 Dose dependency of A C T damage to a tPL For concentrations up
to and including 50% v/v ACT a 250 pglmL a,PI stock w as used, diluted
by half with appropriate combinations of ACT and incubation buffer to
achieve the desired ACT concentration. For concentrations of ACT above
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50% v/v, a 9 2 6 //g/mL a,PI stock w as used (40.5 pL stock in 3 0 0 //L total
to give 125 //g/mL a,PI).
2 .1 .1 .6 The effect o f aged A C T on its ability to damage o,PI. The effect
of aging ACT on its ability to damage a,PI w as studied in tw o ways.
Firstly, fresh ACT or aged ACT (aged for 12 h at 3 7 “C, in th e dark) w as
incubated with a,PI and the EIC determined at 2 and 24 h. Secondly, the
ability of ACT to dam age successive additions of o,PI w as determined as
follows. The EIC of an incubation containing ACT and 125 //g/mL a,PI w as
determined after 24 h ("first 24 h incubation"). The control w as 125
//g/mL o,PI exposed to incubation buffer only. For the EIC assa y s 4 0 //L
(2 x 20 //L) of incubation mixture w as removed from a total of 3 0 0 //L,
leaving 2 6 0 //L of incubation mixture. To this 2 6 0 //L, 2.5 //L of incubation
buffer and 3 7.5 //L of 1 mg/mL a,PI w as added to replenish the ACT
incubation with fully active o,PI (125 //g/mL) for the "second 24 h
incubation". The EIC w as assessed after 0 .7 5 h, to ensure 100% OtPI
activity had been restored, and then again after 24 h. An additional control
for the "second 24 h incubation" consisted of a mixture of 110 //L fresh
ACT plus 150 //L of 2 5 0 //g/mL o,PI and 40 //L of incubation buffer. This
control accounts for the fact that the second a, PI aliquot is exposed to a
diluted ACT com pared to the first exposure.
2 .1 .1 .7 pH change o f A C T over a 2 4 hour incubation period. The pH of
4 .5 mL of freshly prepared ACT w as measured initially and after incubation
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for 2 4 h under the standard conditions. For the sake of correct
comparison, the buffer alone w as incubated under identical conditions and
the pH measured.
2 .1 .1 .8 Exposure to ACT of a,PI enclosed in dialysis tubing. Dialysis
tubing (Spectra/Por 6, Wet-Form, Molecular Weight Cut-Off 1,000;
Spectrum Medical Industries Inc., Los Angeles, CA) w as prepared as
follows: 1) the tubing w as cut into convenient lengths and w ashed inside
and out with deionized water; 2) the tubing w as boiled for 10 min in 500
mL of 2% sodium bicarbonate/1 mM EDTA, and then rinsed with deionized
water; 3) the tubing w as boiled for 10 min in deionized water, cooled and
stored in a refrigerator. The dialysis tubing w as w ashed both inside and
out with deionized water just before use. Two ACT preparations w ere
pooled then diluted by half to give sufficient ACT to work with.
Approximately 5 cm of dialysis tubing, closed at both ends with clips and
containing 4 0 0 pL of 125 //g/mL a,PI w as immersed in 10 mL of either
incubation buffer or ACT in 15 mL screw-cap vials. The vials were
incubated under the standard conditions. The EIC w as determined after
2 4 h.
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2 .1 .2 Results.
2 .1 .2 .1

The estimation o f water soluble particulate matter in ACT. Using

six ACT preparations the following data w ere obtained (mean ± s.d.):
Weight of Cambridge filter extract = 16.15 ± 0 . 1 1 mg
Weight of ACT - 2 0 .3 3 ± 0 .7 3 mg
Weight of non-volatile ACT com ponents in 1 mL ACT
= 4 .1 8 ± 0 .7 4 mg
Thus, the 5 mL of undiluted ACT contains approximately 21 mg of
material. Since tw o 1R1 cigarettes could yield approximately 71 mg of
TPM, then approximately 30% w as extracted into the buffer as relatively
non-volatile material. This material w as diluted by half in order to add a, PI
solution, buffer and other com ponents of the incubation. Therefore, each
experiment contains about 2.09 mg/ml of w ater soluble non-volatile
particulate phase com ponents. This half-dilute preparation is the standard
ACT solution for a, PI exposure and corresponds to the concentration of
w ater soluble particulate matter from one 1R1 cigarette. These data also
illustrate that the extraction procedure is reasonably reproducible, given the
relatively crude preparation method.
2 .1 .2 .2 Time course for EIC loss o f a }P! e x p o sed to A C T and g a s phase
cigarette smoke. Exposure of o,PI to ACT derived from tw o 1R1 cigarettes
ca u ses a monophasic loss of EIC that is similar in extent to that seen for
the first 5 h of exposure to gas-phase extract (Fig 2). In ACT a loss of EIC
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of 6 0-80% is observed over 24 h compared to approximately 50 and 40%
loss of EIC for DGP and GPE exposures, respectively. Aqueous extracts of
a Cambridge filter, w hether exposed, or not, to 2 0 puffs of ambient air, has
no effect on the EIC of o ^ l . The native o,PI displayed the sam e EIC over
the 2 4 h incubation period.
In certain ca ses the am ount of EIC lost by c^PI after exposure to
ACT is dependent on the lot number of o,PI used! This variability w as not
anticipated at the outset of these studies. The reason for this inter-lot
variation in loss of EIC is unknown. However, the variation in loss of EIC
after ACT exposure w as relatively small. The smallest loss of EIC observed
after 24 h incubation with ACT is that show n in Fig 2 {59 ± 6%). Other
experiments show ed greater EIC losses, e.g., a mean % EIC ± s.d. of 23
± 7% for one particular lot-number of o,PI exposed to 42 different ACT
preparations. Despite these relatively large variations in sensitivity to ACT,
the 2 4 h incubation period w as used for the majority of the studies. The
data for the a,PI damaging activities of the ACT derived from the various
research cigarettes are show n in Table 5.
2 .1 .2 .3 Dose dependency o f ACT damage to a,Pl. The ACT ca u ses a
concentration-dependent loss of EIC (Fig 3).
2 .1 .2 .4 The effect o f aged ACT on its ability to damage a tPl. ACT aged
for 12 h at 37 °C show s only slightly less a,PI damaging ability compared
to a fresh sample of ACT {Table 6). Also, ACT has the ability to dam age
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Figure 2. Time courses of the loss of EIC of ff,PI: ACT (■); gas phase
extract ( • ) ; direct gas phase U). Data shown are the mean of three
independent runs; error bars represent s.d. where this exceeds symbol size
(Reproduced with permission from Ref. 190).
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Table 5. A comparison of the effects of ACT from 1R1 and 2R1F research
cigarettes on the EIC of o ^ l .

Cigarette type

% EIC“

1R1

23 ± 7k

2R1F

22 ± 3"

a - These data w ere obtained with the sam e lot number of o,PI. Data are
means ± s.d.
b - 4 2 ACT preparations,
c - 5 ACT preparations.
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Figure 3. Dose dependence effect of ACT on the EIC of o,PI. Data are

mean of three independent ACT preparations; error bars represent s.d.,
w here this exceeds symbol size (Reproduced with permission from
Ref. 190).
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successive additions of or, PI, causing similar losses in EIC (Fig 4). The data
in Table 7 concerning residual PPE activities and % EIC for th e controls is
required for full interpretation of Fig 4. The data in Table 7 should be used
as follows: "control o,PI" displays 8 1% PPE inhibition, and th e "ACT, 0 .7 5
h" show s that after addition to ACT of the second o,Pl aliquot control
levels of PPE inhibitory ability were restored. "Dilute ACT" is m eant to be
com pared with the 4 8 h point on Fig 4, to determine the true difference in
EIC loss due to any depletion of damaging species with aging of ACT. The
data concerning the pH change of ACT incubations are presented in Table
8, and show a consistent decrease of 0.1 pH unit over a period of 24 h.
2 .1 .2 .5 Exposure to ACT o f a,PI enclosed in dialysis tubing. Under the
conditions used for dialysis, a,PI retains its porcine pancreatic elastase
(PPE) inhibitory activity after 2 4 h (Table 9). Data in Table 9 are also
presented for a,PI incubated in buffer only ("native") or ACT under the
standard incubation conditions.
2 .1 .3 Discussion.
In term s of the degree and rate of EIC loss, ACT resembles GPE
more closely. However, these tw o m ethods of exposure are different in
the am ount of cigarette smoke material involved. Material from tw o 1R1
cigarettes w as extracted into different volumes of buffer, 1.5 and 5 mL for
the studies using the gas phase and ACT, respectively. ACT w as further
diluted by 50% for incubations with a,PI, i.e. the material from tw o 1R1
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Table 6

The effect of aged ACT on its ability to dam age hum an c^PP.

Exposure

Incubation time (h)

% EIC
remaining*

Buffer only

2 or 24

100

Fresh ACT

2

90 ± 1

Fresh ACT

24

15 ± 2

Aged ACT*

2

96 ± 1

Aged ACT

24

26 ± 4

a - Reproduced with permission from Ref. 190.
b - Data are means ± s.d. of three ACT preparations,
c - Aged at 37 °C, light protected for 12 h.
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Figure 4. The effect of ACT on the activity of tw o successive additions of
o,PI. Each point show n is m ean of three independent ACT preparations;
error bars represent s.d. (Reproduced with permission from Ref. 190).
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Table 7

Control data for use in conjunction with Fig 4.

Incubation
Dilute ACT, 24 h

% PPE inhibited*
—

% EIC"
25 ± 2

ACT, 0 .7 5 h

86 ± 1

100

Control o,PI

81

100

a - Data are means ± s.d . of three ACT preparations.

Table 8

a b *

The pH change of ACT incubated a t 37

•c.

incubation

pH at 0 h

pH at 2 4 h

50% v/v ACT"

7 .3 8 ± 0.0 3

7 .2 6 ± 0.01

Incubation buffer11

7.41 ± 0 .0 0

7 .3 9 ± 0.01

Data are means ± s.d. of three ACT preparations,
Data are means ± av.dev. of two samples.
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Table 9 The effect of ACT on or,PI enclosed in a dialysis bag with a
molecular weight cut-off of 1,000.

Incubation

% PPE inhibited

% EIC

Dialysis Control

73 ± 4-

100

Dialysis ACT

...

12 ± 1"

Native
ACT
a b c -

78 ± 1h
...

100
2 0 ± 8°

Data are means ± s.d. of three incubations or three ACT
preparations.
Datum is mean ± av.dev. of two separate incubations,
Datum is mean ± s.d. of four ACT preparations.
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cigarettes w as effectively diluted into 10 mL. Thus, the material from tw o
1R1 cigarettes in th e ACT incubations is 6 .7 times less than in the gas
phase system s. The data in Fig 2 and the relative am ounts of cigarette
smoke material in th e gas phase and ACT imply th a t cigarette smoke
particulate matter releases greater am ounts of damaging species and/or
such damaging species are more potent than those derived from gas phase
smoke.
The 1R1 cigarette and its counterpart, the 2R1, is widely considered
the reference research cigarette for chemical and biological studies.
However, although the 1R1 is unfiltered, the addition of a filter tip makes
no substantial difference to the a,PI damaging properties of an ACT
(Table 5).
The experiments concerned with th e aged ACT should furnish
som e information about the stability/turnover of *7,PI damaging species.
The ACT loses little damaging capability with aging, thus indicating that
the damaging species are relatively stable. Also, ACT can generate more
than enough species to damage successive additions of o,PI. If damaging
species accumulate in ACT with aging then the loss of EIC of o^PI exposed
to aged ACT would be more rapid if the damaging reaction(s) is fast. The
assessm en t of EIC at 2 h show s that either damaging species do not
accumulate, or they do accumulate but the damaging reaction(s) is slow.
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Data presented later in the dissertation (section 3.2.3.21 indicate that the
latter conclusion is probably correct.
Since the pH of ACT does not change drastically over 2 4 h, pH
ch ang e is not responsible for the EIC loss of o,PI. Alpha,PI is relatively
resistant to pH change and loses only 35% activity w hen the pH is
decreased from 7.5 to 5.0 (191). However, below pH 5.0 th e proteinase
inhibitory activity drops precipitously (191). Some or all of the EIC loss
suffered by o,PI exposed to ACT could be due to particulates either initially
present or formed over time in ACT. Such particulates may adsorb o,PI,
for example, and remove it from solution to give the appearance of EIC loss
due to molecular dam age. While other data in the dissertation support
molecular dam age as the reason for EIC loss, the data from th e dialysis
experiment imply that EIC loss is not due to particulates initially present in
ACT. However, high molecular weight polymeric material could form from
species entering the dialysis bag early on in the incubations. Both fresh
and aged ACT show ed no visual evidence of particulates, even though
smoke solutions have been noted to form polymeric material upon aging
(192).

Z 2. The Assay of Elastase Inhibitory Capacity.
Porcine pancreatic elastase (PPE), rather than HNE, is used
frequently for determining o,Pl activity. Both enzym es are inhibited by
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a, PI, but the kmw values for this interaction are different, 6.5 x 10T and
1.0 x 10* M ’.s'1 for HNE and PPE respectively (55). The m ost dramatic
change in

values is noted for o,PI containing MetSO36*, where the

values are 1.0 x 10s and 0 M ' V for HNE and PPE, respectively (55).
2 .2 .1 Experimental.
2 .2 .1 .1 A s s a y protocol. The activity of PPE (Pancreatopeptidase E, E.C.
3 .4 .2 1 .3 6 ; 140 U/mg; Calbiochem Corp., San Diego, CA) w as measured at
pH 8 .0 and 25 °C according to the method of Bieth e t al. (193). The
reaction mixture in a final volume of 1 mL contained 0 .2 M Tris*-HCI, pH
8.0, 0 .1 4 U PPE, 2.5 //g o,PI. 1 mM N-succinyl-(L-Ala)3-p-nitroanilide
(SANA) and 0 .8 % v/v 1-methyl-2-pyrrolidinone. The PPE w as
preincubated with native or treated ^ P l (usually a 2 0 pL aliquot of 125
PQ/mL o,PI) for 5 min at 25 °C and the reaction started by the addition of
SANA. The increase in absorbance at 4 1 0 nm w as measured against a
reference consisting of buffer and SANA only. The initial linear rate of
absorbance change due to uninhibited PPE w as taken as 100% PPE
activity; the decrease in this rate due to native a, PI w as taken as 100%
EIC. The % EIC w as calculated using equations 10 to 12 (overleaf).
Control values for uninhibited PPE were determined under identical
conditions, but with omission of a,PI from the assay mixture.
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% PPE active ■* 1OO[(AA410 min'1, D/fAA^o min'1, U)]

(10)

% PPE inactive = 100 - % PPE active

(11)

% EIC =

(12)

100[(% PPE I. a 1PI*)/(% PPE I, o,PI)]

Where, "AA410 min'1, I" is the initial rate for PPE activity in the presence of
OtPI; "AA410 min'1, U" is the initial rate for PPE activity in the absence of
o,PI; "% PPE I, t^PI*" is the % PPE inactive in the presence of o,PI
exposed to som e treatm ent; "% PPE I, a , P r is the % PPE inactive in the
presence of r^PI exposed to incubation buffer only.
2 .2 .1 .2 Effect of ACT on PPE activity and the abiiity o f a,P! to inhibit PPE.
Normally, 20 /yL aliquots of sample containing c^PI and 50% v/v ACT were
used in the EIC assay, thus ACT w as present at (20 i/L/1000/yL) 1% v/v in
the assays. To test the effect of ACT on PPE activity, the assay was
conducted as described in section 2 .2 .1 .1 , substituting the 20 jyL aliquot of
o,PI sample with 20 jjL of 85% v/v ACT (aged for 24 h under the standard
conditions). In a similar experiment 2% v/v ACT w as te sted for any
effects on the ability of undam aged a,PI to inhibit PPE. The assay for this
experiment w as conducted as described in section 2 .2 .1 .1 , except that
4 0 /sL of 50% v/v ACT w as substituted for an equivalent volume of ass ay
buffer.
2 .2 .1 .3 Estimation o f the a tPf:PPE ratio in the assa y mixture and its effect
on EIC determination. The concentration of a,PI w as determined by
calculation as described in section 2 .2 .2 .3 . The PPE concentration w as
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determined using a method described by Shotten (194). Stock solutions of
PPE (100 |/g/mL) w ere prepared in 0.1 M sodium hydroxide. Dilutions of
0 .5 and 0 .7 5 of the stock solutions w ere made with 0.1 M sodium
hydroxide, and the absorbencies m easured at 2 8 0 nm against a 0.1 M
sodium hydroxide blank.
The effect of the r^PhPPE ratio on EIC determination w as examined
by assessing the % EIC of ACT-damaged a,PI using a 10 or 20 /A. aliquot
of a,PI sample for the EIC assay. Incubations of a,PI in buffer alone or
with ACT were performed under the standard conditions.
2 . 2 . 1.4 The incubation time of PPE with a tPi. The standard EIC assay
protocol, section 2 .2 .1 .1 , includes a 5 min co-incubation of o,PI and PPE to
achieve inhibition before the addition of SANA. In the literature, the
selection of this time is dependent on various factors such as the
incubation tem perature and the concentration of a,PI in the sample.
Although this 5 min time w as always used, som e experiments were
performed to asse ss the effects of increasing this time on the inhibition of
PPE and the EIC values. These studies simply involved incubating native or
ACT-exposed a,PI for differing times and determining the PPE activities.
2 .2 .2 Results and Discussion.
2 . 2 . 2 . 1 Effect o f A C T on PPE activity and the ability o f a tPI to inhibit PPE.
Data from four experiments gave 102 ± 1 % PPE activity (mean ± s.d.) in
the presence of 1.7% v/v ACT. Incubation of native o,PI with PPE and 2%
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v/v ACT had no effect on the degree of PPE inhibited. T hese data imply
that the 1 % v/v ACT present in the EIC assay of ACT-exposed o,PI is
highly unlikely to affect either PPE activity or the ability of o,PI to inhibit
PPE.
2 .2 .2 .2

The incubation time of PPE with a,PL Since o,PI activities were

always expressed relative to a control, i.e. as % EIC, the effects of various
treatm ents on the activity of a,PI could be easily com pared. The use of
% EIC also com pensates for any inherent variations in the native {i.e.
untreated) a,PI activity. The degree of inhibition of PPE w as relatively
consistent within a lot number of a, PI. Five different lots of ^ P l gave the
following m eans ± s.d. (sample size in parentheses) for percent PPE
inhibited (after co-incubation of o,PI with PPE for 5 min): 7 4 ± 2 (n =4),
91 ± 1 (n = 4), 70 ± 4 (n = 11), 81 ± 2 <n = 8) and 87 ± 4 (n = 17).
Figure 5 sh o w s the effects of increasing the a,PI/PPE incubation time on
the percent PPE inhibited. Doubling the o,PI/PPE incubation time from 5 to
10 min results in an increase the % PPE inhibited. When considering the
ACT-damaged ff,PI, an increase in the a,PI/PPE incubation time from 5 to
10 min leads to a 5-10% increase in the calculated EIC values. These
changes in EIC resulting from an increased a,PI/PPE incubation time are
relatively small and the effects are not transmitted to the % protection data
(section 3.1.1.1 ) such that changes in the interpretation of th e results are
necessary.
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Figure 5. The effect of variation of the cr,PI/PPE incubation time on the
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2 .2 .2 .3 Estimation o f the a,Pi:PPEratio in the a ssa y mixture and its effect
on EiC determination. In the EIC assay, 20 pL of a 125 pgimL a,PI solution
is added to 9 6 2 pL assay buffer and 10 pL PPE stock; 20 pL 125 pg/mL
o,PI in 9 9 2 pL total = 2.52 ^g/mL a,Pl; MW a,PI * 5 2 ,0 0 0 .
Therefore w e have, 2 .5 2 p g /5 2 ,0 0 0 = 4 8 .4 6 pmoles o r , PI/mL.
Thus, la,PI] in assay mixture = 4 8 .4 6 nM.
For PPE, €2e0om = 5.74 x 104 M 1 cm 1 (194)
[PPE] = (1/dilution factor }(A280/ f 2ao)
Dilution factor = 0.5 or 0.75 as appropriate.
For four m easurem ents, 0.5 and 0.75 dilutions of tw o separate stocks:
[PPE] in stock - 2.19 ± 0.19^/M
[PPE] in assay - 2.19 x (10/992) = 22.1 nM
Therefore a,PI:PPE ratio in assay = (48.46/22.1) = 2.2
The results of varying the volume of the a,PI sample aliquot, and
hence the ratio of a,PI/PPE, are presented in Table 10. The data indicate
that lowering the ratio of a,PI to PPE from approximately 2 to 1 results in a
negligible difference in the EIC value. Finally, the reason for selecting
20 pL samples for the EIC assay is that this sample size of native a,PI gives
the greater inhibition of PPE w hen the pre-incubation time of 5 min w as
used.
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Table 10. The effect of alteration in the a,PI:PPE ratio in the EIC assay
mixture on the m easurem ent of EIC.

Assay volume,

% PPE

Ml?

inhibitedb

Native-OjPI

20

72 ± 2

100

ACT-OtPI*

20

31 ± 5

43 ± 6

Native-o,PI

10

40 ± 1

100

ACT a, PI

10

16 ± 4

40 ± 8

Sample

a - Volume added to assay cuvette,
b - Data are means ± av.dev. for tw o ACT.
c - o,PI exposed to ACT.

% EIC

CHAPTER 3

INVESTIGATION OF THE MECHANISM OF DAMAGE TO or,PI BY AQUEOUS
CIGARETTE TAR EXTRACT.

3J_ Protection Studies.
Protection studies have been used effectively in numerous
biochemical studies and have been applied to c^PI/cigarette smoke
interactions (130,133,135). They are used in this dissertation in an
attem pt to elucidate the mechanism of ACT dam age to c^PI. For the
purposes of this dissertation, modifications of o,PI structure that do not
affect EIC are not regarded as damaging, although such modifications could
affect other properties of the protein.
Since there is pre-existing evidence that cigarette smoke causes
oxidative dam age to biological targets this w as used as a starting point for
the studies. A variety of agents were tested in the ACT system for
protective effects tow ard o,PI. In the majority of c a ses the experimental
procedure w as the sam e, but there were som e variations. Some enzymes
were used to probe the damaging mechanism, and as such it proved
necessary to determine the effects of ACT on the activity of these
enzymes and their assay systems.
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3 . h 1 Exeerimentaf.
3 .1 .1 .1

Standard protocol for incubation o f a fPf with A C T p/us additives.

The incubations contained ACT, a,PI and appropriate am ounts of additives
to probe the mechanism of dam age. The effects of the additives alone on
c^PI w ere also studied using controls that contained 125 //g/mL a,PI and
the additives in incubation buffer. Incubations aimed at determining the
effect of ACT alone contained 125 /;g/mL o,PI in ACT plus incubation
buffer to substitute for th e additive. Unless otherwise indicated, the
incubations w ere performed in closed vials, under the conditions described
in section 2 .1 .1 .3 and the EIC w as determined after 2 4 h.
Data derived from incubations containing additives are reported as
percent protection. Percent protection is calculated as show n in equations
13 and 14:
% protection = 100 - % dam age

(13)

% dam age = 100.{[100 - %EICA]/I100 - %EICJ}

(14)

Where, "%EICA" is the % EIC calculated for o,PI incubated in ACT plus an
additive and "%EICB" is the % EIC calculated for o,PI incubated in ACT
only.
A percent dam age of 100 is defined as the effect of ACT alone on
a, PI. For a,PI exposed to ACT in the presence of additives: 100% dam age
implies the additive has no effect: < 100% dam age implies the additive
protects or, PI; > 100% dam age implies the additive enh ances ACT dam age
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to a,PI. Percent protection, rather than percent dam age, is used routinely
to make the data compatible with the previous studies of Pryor e t at. (130).
3 .1 .1 .2 The effects o f free amino acids on the a,P/-damaging ability o f
ACT. The amino acids were present in the incubations at 10 mM;
methionine and cysteine were also tested at 1 mM. Stock solutions of
methionine and cysteine w ere prepared fresh before each experiment. Due
to their poorer solubility, tryptophan and phenylalanine were added as
solids to the incubation vials, such that addition of 3 0 0 pL of solution gave
10 mM of each amino acid.
3 .1 .1 .3 The effects o f reducing species and hydroxyI radical scavengers
on the afPI-damaging ability o f ACT. All stock solutions w ere prepared in
incubation buffer; the thiol and ascorbate stock solutions w ere prepared
fresh at the start of each experiment. Some incubations of a,PI with ACT
and 10 mM ascorbate, reduced glutathione (GSH), cysteine, dithiothreitol
(DTT), methionine or thiourea were performed under air-purged conditions.
Air-purged incubations comprised a total volume of 5 0 0 gL in 2 mL glass
vials fitted with screw -caps housing teflon septa. Capillaries cut from a
used capillary gas-chromatography column w ere used to introduce
com pressed air into the vials. Each vial w as hooked-up to an air cylinder
via a capillary inserted through the septum and each vial w as also supplied
with a short exhaust capillary. Only the headspace w as continually purged,
as purging through the solution for 24 h resulted in EIC loss of the control.
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The vials w ere incubated under the standard conditions and EIC w as
a ssessed after 24 h.
3 .1 .1 .4 The effects o f metaf ion cheiators and ferric ions on the a,Pidamaging ability of ACT. The standard incubation protocol and conditions
w ere followed as detailed in section 3 .1 .1 .1 ; after 24 h the EIC w as
determined. In most ca se s the stock solutions w ere prepared in incubation
buffer. A few stocks were prepared differently; desferrioxamine mesylate
(Desferaf) w as prepared in deionized water; diethylenetriamine
pentapentaacetic acid (DTPA) w as prepared in 0 .6 M sodium hydroxide;
ferric chloride w as prepared in 0.01 M hydrochloric acid. In ca se s where
DTPA and ferric ions w ere added, the introduction of base or acid,
respectively, did not affect the pH of the incubation buffer.
3 .1 .1 .5 Studies using cata/ase. The activity of catalase (H20 2: H20 2
oxidoreductase, E.C. 1.11.1.6; from bovine liver, thymol-free, 1 1 ,0 0 0
U/mg solid, 1 4,10 0 U/mg protein; Sigma Chemical Co., St Louis, MO) w as
determined using the method described by Claiborne (195), in which the
disappearance of absorbance at 2 4 0 nm is monitored. The concentration
of the substrate (hydrogen peroxide) w as 20 mM in incubation buffer. The
initial hydrogen peroxide concentration w as slightly different betw een
experimental runs, but w as always ca. 20 mM. Since the results were
frequently expressed relative to a control, this slight variation w as not a
problem. In the assay, an aliquot (2 to 10 /sL, depending on the catalase
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concentration) of sample w as added to hydrogen peroxide substrate to give
a 1 mL assay volume. The change in absorbance at 2 4 0 nm w a s followed
for a maximum of 30 s, using a hydrogen peroxide substrate reference.
Data are expressed as initial rates, A A ^ . s '1 and/or percentage control
activity. The catalatic activity of each incubation w as a ssessed in
triplicate.
Several preliminary experiments were conducted to determine the
effect of single additions of catalase on the activity of a,PI exposed to
ACT, and the effect of ACT on these relatively low catalase
concentrations. Aliquots (2 to 10 pL) of catalase stock solutions in
incubation buffer w ere added to incubations of o,PI and ACT to achieve the
desired concentrations of catalase. The incubations w ere carried out as
outlined in section 3 .1 .1 .1 , and the incubates w ere a s se ss e d for EIC or
catalase activity. Control incubations were also prepared to determine the
effect of catalase p er s e on a,PI activity.
The activity of 5 5 0 0 U/mL catalase exposed to ACT w as determined
at selected intervals over an 8 h incubation period. Incubations consisted
of 1 mL (containing 20 pL of a 2.75 x 10s U/mL catalase stock) in
Eppendorf vials of 1.5 mL capacity. Control incubations contained catalase
in incubation buffer only, while ACT incubations contained 0 .5 mL of ACT,
20 pL of catalase and 0 .4 8 mL of incubation buffer. The activity of
catalase in each sample was determined in triplicate at each time point
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using a 2 pL aliquot for the assay. A further experiment w as performed
involving addition of catalase at 0, 4 and 12 h during the 2 4 h incubation
period; a "multiple addition" protocol. The incubations w ere as described
for th e previous experiment, except that at 4 and 12 h, 20 p t of 2.75 x
106 U/mL catalase stock w as added. The catalase activity w as determined
after 24 h incubation under the standard conditions. After th e final
addition of catalase, the incubations would contain 15,692 U/mL, if all the
catalase remained active.
The sam e multiple addition protocol w as applied to o,PI incubations
with ACT. The following incubations (300 pL volume in 500//L Eppendorf
vials) were performed: 1. OtPI control; 2. c^PI + catalase; 3. OtPI + ACT;
4. c^PI + ACT + catalase. The initial volumes for incubation J_ were 150
pL of 2 5 0 pQ/mL o,PI stock plus 150 pL of incubation buffer, for incubation
2, 6 pL of 2 .7 5 x 10* U/mL catalase stock w as added in place of an
equivalent volume of buffer. For the ACT incubations; 2 received 150 pL
of a,PI stock, 144 pL of ACT and 6 pL of incubation buffer, 4 received 6
p i of catalase stock instead of buffer. At 4 and 12 h, incubations J. and 2
received 6 p L of buffer, w hereas incubations 2 and 4 received 6 pL of
catalase stock. The EIC values were determined after 24 h incubation
under the standard conditions.
3 .1 .1 .6 The effect o f heat denatured catalase and BSA on the activity o f
a,Pi exp osed to ACT. Catalase was prepared as a 25 mg/mL solution in
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incubation buffer and inactivatoiJ at 100 °C for 3 - 4 min. The mixture w as
then homogenized by vortexing and brief sonication. The catalase assay
(section 3.1.1.5) w as used to confirm that the heat-denatured catalase had
no activity. Heat-denatured catalase was added to o,PI in incubation buffer
only or in ACT by the multiple addition protocol (section 3.1.1.51. The
concentration of heat-denatured catalase w as thus equivalent to that of
active catalase (1.12 mg protein/mL). The EIC values w ere determined
after incubation for 2 4 h under the standard conditions.
Standard incubation protocols were followed for the o,PI incubations
with bovine serum albumin (BSA; essentially fatty acid free,
fraction V; Sigma Chemical Co.) in buffer or ACT. The BSA stock solutions
were prepared in incubation buffer and the concentrations in the
incubations were either 0 .5 8 or 5 mg protein/mL.
3 .1 .1 ,7 Studies using superoxide dismutase. The activity of superoxide
dism utase (SOD; superoxide: superoxide oxidoreductase, E.C. 1.1 5.1 .1 ;
from bovine erythrocytes, 3 36 0 U/mg solid, 3 3 6 0 U/mg protein; Sigma
Chemical Co.) w as determined by the method described by McCord and
Fridovich (196). This assay is based on the inhibition, by SOD, of the
reduction of ferricytochrome c to ferrocytochrome c by superoxide
generated by a xanthine/xanthine oxidase system (X/XO; xanthine: oxygen
oxidoreductase, E.C. 1.2.3.22; grade I, from buttermilk, 25 U/1.5 mL, 41
mg protein/ml, 0 .4 2 U/mg protein; Sigma Chemical Co.). The reduction of
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ferricytochrome c (Type IV, from horse heart; Sigma Chemical Co.) by
superoxide and its inhibition by SOD w ere monitored by observing
ferrocytochrome c formation at 550nm. The true change in the absorbance
due to the xanthine dependent reaction w as obtained by subtracting a nonxanthine dependent control rate (all com ponents except xanthine present).
The reference for ail runs w as 20 fjM cytochrom e c in assay buffer.
Since all assay stock solutions were prepared in concentrated form,
most of the assay volume w as deionized water. Both the assay buffer and
w ater were purged with oxygen before use. The contents of the assay
cu vettes w ere as follows;
1. Control X/XO rate in absence of SOD: a total volume of 1 mL
contained 50 mM sodium phosphate, pH 7.6, 1 mM DTPA, 20 */M
cytochrom e c, 5 mU XO and 2 5 0 pM X.
2. The SOD assay contained ail the com ponents noted in 1, plus 5
fjL of SOD sample in place of an equal volume of water.
Before the addition of X the basal AA560 w as monitored for
- 120 s, then after addition of X, the AAB5C w as followed for a further
120

s, over which time the change w as linear.
Studies on the effects of ACT on the SOD assay were done by

monitoring ferrocytochrome c formation and XO activity (formation of urate
at A29B). These studies used ACT which had been incubated under the
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standard conditions before use; 0 .5 % (10^L sample) or 0 .2 5 % v/v (5 pL
sample) ACT w ere tested.
Preliminary studies on the effect of ACT on SOD involved incubation
of either 200 or 546 U/mL SOD with ACT under th e standard conditions
{3.1.1.1). The SOD activity w as determined periodically. An incubation of
SOD in buffer alone w as used as a control. Determination of SOD activity
w as done at 1, 4 and

8

h from the start of the incubation. The SOD

concentrations in the assay cuvettes were 1.0 and 2 .7 3 U/mL for the 200
and 546 U/mL incubations, respectively. Also, 182 U/mL of SOD and
5 5 0 0 U/mL of catalase were co-incubated in ACT for 1 h, and the SOD
activity w as determined. These experiments involving co-incubation of
SOD and catalase w ere used with appropriate controls to determine if
hydrogen peroxide w as involved in damage to SOD caused by ACT.
A multiple addition protocol w as used to te st the effect of SOD on
ACT dam age to a, PI. Incubations of SOD in ACT or buffer w ere used in
preliminary experiments to determine survival of SOD in ACT. Aliquots of
5 pL of an SOD stock in incubation buffer (36960 U/mL) were added to the
incubations at 0, 4,

8

and 12 h from the start of the incubation. Since the

final incubation of SOD (315 //L) contained 2 0 pL of this stock, the
concentration of SOD w as 2347 U/mL. SOD activity w as measured at 3,
7, 11 and 24 h.
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The incubations of a,PI with SOD in 50 0 pL Eppendorf vials w ere as
follows: 1. a,PI control; 2. o,PI + SOD; 3. o,PI + ACT; 4. otPI + ACT +
SOD. The initial volumes for incubation 1 were 150 pL of 2 5 0 /jg/mL a,PI
stock plus 150 pi. of incubation buffer; for incubation 2, 5 pL of 3 6 9 6 0
U/mL SOD stock w as added in place of an equivalent volume of buffer.
For the ACT incubations; 2 received 150 pL of a,PI stock, 145 pL of ACT
and 5 pL of incubation buffer, 4 received 5 pL of SOD stock instead of
buffer. At 4,

8

and 12 h, incubations 1 and 2 received 5 pL of buffer,

w hereas incubations 2 and 4 received 5 pL of SOD stock. The EIC values
were determined after 24 h incubation under the standard conditions.
3 ,1,2 Results.
3 .1 .2 .1

The effects o f free amino acids on the a ,Pi-damaging ability o f

ACT. Only the sulfur containing amino acids show any protection of c^PI.
While Met sh o w s protection at 1 mM, Cys protects only at 10 mM (Table
11). The amino acids alone, at the highest concentration used, had no
effect on the activity of o,PI.
3 .1 .2 .2 The effects o f reducing sp ecies and hydroxyl radical scaven gers
on the a,Pl-damaging ability o f ACT. Control incubations indicated that 10
mM GSH, DTT, thiourea, 5 mM oxidized glutathione (GSSG), and 50 mM
benzoate and mannitol p er se. did not affect the EIC of or, PI. Ascorbate
alone did affect the EIC of o,PI; at 1 and 10 mM the mean % EIC ± s.d.
values were 8 0 ± 5 and 87 ± 5% , respectively, after a 24 h incubation.
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Table 11. The effects of various L~amino acids on the ability of ACT to
dam age a^PI.
Amino Acid*

% Protection*

Alanine

4 ±

Arginine

3 ± 4

Cysteine

70 ± 7
±

6

Cysteine, 1 mM

10

Histidine

0

±

Lysine

8

± 5

6

6

Methionine

80 ± 3

Methionine, 1 mM

47 ± 3

Methionine Sulfoxide

8

± 4

Phenylalanine

4 ± 3

Proline

7 ± 3

Serine

7 ± 3

Tryptophan

4 ± 3

a - All at 10 mM, unless indicated otherwise,
b - Data are mean ± s.d. of three ACT preparations.
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To account for ascorbate exerting this effect in ACT exposures, the % EIC
values for a,PI incubated with ACT and ascorb ate w ere calculated using
the % I values (see equations

10

to

12

, section

2 .2 . 1 . 1

) obtained for

incubations of a^P\ with ascorbate only. The data on th e effects of
reducing species and hydroxyl radical scavengers on the a,Pl-damaging
ability of ACT are show n in Table 12, while Table 13 sho w s th e effect of
som e of th e se species under continuously air-purged conditions.
3 .1 .2 .3 The effects o f m etal ion chelators and ferric ions on the a,Pldamaging ability of ACT. None of the chelators or ferric ions, a t the
highest concentrations tested, had any effect alone on c^PI activity; the
data are show n in Table 14.
3 .1 .2 .4 Studies using catalase. The effect of - 5 to 175 U/mL catalase
on a,PI exposed to ACT w as tested, as w as the effect of ACT on - 9 0 to
1 4 5 0 U/ml catalase. Usually only one run of th ese experim ents was
performed, and taken together the experiments sh o w th a t catalase at these
relatively low concentrations is poor at protecting ^ P l , probably
becau se the activity is lost during ACT exposure (Tables 15 and 16). In a
separate study (using one ACT preparation) catalase concentrations of
1100, 55 00 and 1100 0 U/mL protected o,?! by 33, 33 and 55% ,
respectively. Catalase alone at these concentrations did not inhibit a,PI
activity.
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Table 1 2 . The e ffe c ts o f reducing s p e c ie s and hydroxyl radical scavengers
on AC T-m ediated dam age to a,PIV

Additive

% Protection*

1 mM GSH

13 ±

6

10 mM GSH

89 ± 4

5 mM GSSG

15 ± 4

1 mM DTT

3 ± 1

10 mM DTT

75 ± 2

1 mM Ascorbate

3 ± 4

10 mM Ascorbate
1

mM Thiourea

10 mM Thiourea

86

± 5

55 ± 5
66

±

1

50 mM Benzoate

0 ± 5

50 mM Mannitol

6

a - Based on Table 2 in Ref. 190, with permission,
b - Mean ± s.d. of three ACT preparations.

± 5
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Table 13. The protective action of GSH, ascorbate, cysteine, DTT,
methionine and thiourea toward or,PI in ACT under continuously air-purged
conditions.

Additive*

% Protection 11

Cys

43 ± 2

GSH

72 ± 4

Ascorbate

51 ± 7

DTT

33 ± 2

Methionine

89 ± 1

Thiourea

84 ± 2

a - 10 mM.
b - Mean ± s.d. of three ACT preparations.

81
Table 1 4 . The e ffe c ts o f m etal Ion chelators and ferric ion s on th e activity
o f o 1PI e x p o se d to ACT.

Additive
1 0 //M DTPA

% Protection*
1

±

1

10 mM DTPA

31 ± 3 b

10 f*M EDTA*

9 ± 3

10 mM EDTA

42 ± I 4

10 mM EDTA + 50 mM Benzoate

32 ± 4

10 mM EGTA
5 0 0 I'M Desferal*
5 mM Desferal*
10 mM Bathocuproine Disulfonate
10 mM DDC

14 ±
6

6

± 4

-7 ± 4 b
11

±

6

53 ± 2

20 mM HIMDA

22

10 uM Fe3+

2

±
±

6
2

100 $jM Fe3+

32 ± 2

2 0 0 //M Fe3+

25 ± 4*

20 0 //M Fe3+ + 50 mM Benzoate

28 ± 4

a - Mean ± s.d. of three ACT preparations, unless otherw ise indicated,
b - Mean ± s.d. of five ACT preparations.
c - Abbreviations: EDTA, Ethylenediamine tetraacetic acid; EGTA,
(Ethylenedioxy)diethylenenitrilo tetraacetic acid; HIMDA,
N-(2-hydroxyethyl)iminodiacetic acid,
d - Mean ± s.d. of eight ACT preparations,
e - Mean ± s.d. of six ACT preparations.
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Table 1 5 . The e ffe c t o f low con cen tration s o f c a ta la se on th e activity o f
o.,PI e x p o se d to ACT.

[Catalase], U/mL

% Protection*

5.5

21

11.0

27

2 2 .0

23

4 4 .0

24

8 8 .0

27

176.0

29

a - One ACT preparation.
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The substrate alone displays a negligible intrinsic d ecrease in A240.
Alpha,PI and ACT, either alone or in combination with ACT, have no
catalatic activity (Table 16).
Most of the catalase activity (ca. 40% ) is lost in the first 4 h and
only ca. 5% in the subsequent 4 h of incubation (Table 17). The
experiment in which catalase w as added to ACT using a multiple addition
protocol show ed that after 24 h, 101 ±

8

% (mean ± s.d.; three separate

ACT preparations) of the catalase activity remained as com pared to the
control incubations.
When the multiple addition protocol w as used for or, PI protection
studies the % protection w as 82 ± 1% (mean ± s.d.; three separate ACT
preparations). Additions of catalase alone did not affect the EIC of a, PI.
3 . 1.2.5 The effect o f heat-denatured catalase and BSA on the activity of
a fPl ex p o sed to ACT. Heat-denatured catalase w as used to ensure that
catalase protection w as due to catalytic activity rather than non-specific
scavenging of damaging species due to the presence of protein. Also,
general protein protective ability w as tested using BSA. Heat-denatured
catalase and 5 mg/ml BSA protect a,PI from ACT dam age to a small extent
(Table 18). The heat-denatured catalase, and BSA (5mg/mL), p e r se had
no effect on th e EIC of a,PI.
3 .1 .2 .6 Studies using superoxide dism utase. Similar to the studies with
catalase, the effect of ACT on SOD w as com pared to controls. Therefore,
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Table 1 6 .

The a ffec t o f ACT on th e activity of c a ta la se.

Incubation

Initial Rate* x 10 '3
AA24Q.S

% Control
Activity

176 U/mL Catalase (rows 1 - 3)
Catalase + a, PI

6.2 ± 0 .3

100

a, PI + ACT

0

0

a, PI + catalase + ACT

0 .5 ± 0 .2

8

Catalase, 363 U/mL

3 5 .0 ± 2 .0

100

Catalase, 737 U/mL

70.2 ± 4 .7

100

Catalase, 1 1 0 0 U/mL

90,1 ± 4 .6

100

Catalase, 1463 U/mL

101.8 ± 4.2

100

1
2
3

Catalase, 363 U/mL + ACT

1.1

±

0.2

3

Catalase, 737 U/mL + ACT

2 .6

±

1 .8

4

Catalase, 1100 U/mL + ACT

3 .4 ± 0 .9

4

Catalase, 1463 U/mL + ACT

5 .4 ± 1.6

5

a - Rates are means ± s.d. of triplicate determinations on incubations. In
all ca ses the experiments w ere run with one ACT preparation.
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Table 17.
8 hours.

The activity of catalase (5 5 0 0 U/mL) exposed to ACT for up to

Time, h

% Control Activity

0 .5

81

3.5

69

4 .0

62 ± V

6.5

64

8 .0

56 ± 1“

a - Mean ± av.dev. of two ACT preparations.
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T able 1 8 . The a ffe c ts o f heat-denatured ca ta la se and BSA on the activity
o f a,PI e x p o se d to ACT.

Incubation

% Protection

Heat-Denatured Catalase

29 ± 5*

BSA, 0 .5 8 mg/mL

9 ± 1h

BSA, 5 mg/mL

36 ± 1"

a - Mean ± s.d. for six ACT preparations,
b - Mean ± s.d. for three ACT preparations.
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there w as no need to determine absolute activity of SOD. The assay
system for SOD w as noticeably affected by ACT. The results concerned
with th e se effects are noted in Table 19.
The basal rate of ferricytochrome c reduction is higher in the
presence of ACT than in its absence (Table 19). This result is consistent
with a previously reported observation (197). Since the basal rate of
ferricytochrome c reduction in the presence of ACT is increased, one would
expect to see an increased rate of reduction in the presence of X/XO as
com pared to X/XO alone. However, the rate of reduction by X/XO is
approximately 30% lower in the presence of ACT (Table 19). In the
presence of ACT, XO activity itself w as approximately 10% lower than in
the absence of ACT. Thus, a portion of the ACT-mediated d ecrease in the
rate of ferricytochrome c reduction may be due to inhibition of XO. The
effect of ACT could also be explained by oxidation of ferrocytochrome c or
scavenging of superoxide, although the latter explanation is more likely in
view of the aforementioned results (197). Lowering the concentration of
ACT leads to a lowered basal rate of ferricytochrome c reduction, but the
rate is not restored to control levels, and the X/XO rate is still inhibited. A
5 fjL SOD sample w as used in the assays (section 3.1.1 .7) so as to keep
the ACT concentration low.
The results in Table 20 are expressed as "% Reduction". Percent
reduction is used as a measure of the rate of cytochrom e c reduction in the
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Table 1 9 ,

S tu d ies on th e e ffe c ts o f ACT on the SOD a ss a y sy s te m .

•Rate x 1 0 3, A A ^ .m in '1
Sample

Basal

Enzymatic

Corrected*

X/XO

4 .6 ± 0.1

6 7 .6 ± 1.2

6 3 .0 ±

1 .2

X/XO + 10//L

14.1 ± 0 .3

57.5 ± 1.1

4 3 .4 ±

1.1

51.1 ± 0 .4

4 2 .7 ± 0 .4

ACT
10 /yL ACT

13.8 ± 0 .3

X/XO + 5pL

8 .4 ± 0 .2

ACT
5 /sL ACT

8.7 ± 0.2

Cytochrome c

3.8 ± 0.1
"Rate x 10 3, A A ^ .m in '1

X/XO

3 3 .4 ± 0 .2

X/XO + 10/yL

30.3 ± 0.1

ACT

a - Cytochrome c reduction; mean ± av.dev. of tw o
determinations,
b - Corrected = enzymatic - basal.
c - Urate formation; mean ± av.dev. of tw o determinations.
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Table 2 0 .

The e ffe c t o f ACT on th e activity o f SOD over 8 hours.

Incubation"

% Reduction

2 0 0 U/mL SOD (rows

1

-

6

)

1

Control SOD, 1 hr

29

2

SOD + ACT, 1 hr

79

3

Control SOD, 4 h

24

4

SOD + ACT, 4 h

73

5

Control SOD,

8

h

25

6

SOD + ACT,

8

h

87

5 46 U/mL SOD (rows 7 - 1 2 )
7

Control SOD, 1 h

11

8

SOD + ACT, 1 h

54

9

Control SOD, 4 h

17

10

SOD + ACT, 4 h

58

11

Control SOD,

8

h

14

12

SOD + ACT,

8

h

49

a - One ACT preparation.
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presence of SOD as a percentage of the rate in th e ab sen ce of SOD. The
control ferricytochrome c reduction rate for th e incubation of SOD in buffer
only w as th a t due to X/XO; the control rate for SOD incubated in ACT w as
that due to X/XO plus 0 .2 5 % v/v ACT. Presentation of the data as %
reduction allows chan ges in the control SOD activity to be monitored. The
data illustrate that SOD is sensitive to ACT. Over

h at 3 7 °C, native SOD

8

activity remained stable. Instead of using "% Reduction", the % SOD
activity is estim ated using equation 15:
% SOD activity = 100.{[100 - A]/[100 - B]>

(15)

Where "B" is the % reduction in the presence of native SOD and "A" is the
% reduction in the presence of SOD treated with ACT. Approximately
50% of the activity of 5 4 6 U /m t SOD w as lost after

8

h of exposure to

ACT. For both 20 0 and 546 U/mL SOD m ost of the activity loss occurred
within 1 h ( — 60% for 2 0 0 U/mL and ~ 50% for 546 U/mL).
The reason(s) for the loss of SOD activity in ACT is unknown.
However, one experiment dem onstrated that the loss of SOD activity w as
not dependent on hydrogen peroxide. Using tw o sep arate ACT
preparations, incubation of 182 U/mL SOD in ACT resulted in - 60% loss
of SOD activity compared to the control. Co-incubation of 182 U/mL of
SOD and 5 5 0 0 U/mL of catalase ACT for 1 h, resulted in the sam e loss of
SOD activity as seen for ACT alone. Controls show ed that: catalase did
not have any detectable SOD activity; catalase did not interfere with the
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activity of SOD; catalase slightly decreased the ACT enhanced rate of
ferricytochrome c reduction.
Despite the sensitivity of SOD to ACT, estim ated SOD activity
varies b etw een - 3 0 and 70% over 24 h, w hen SOD is added to ACT
using the multiple addition protocol (Table 21). Although th e se activities
w ere not ideal, they w ere preferable to a single addition experiment. If
superoxide plays some important role in the ACT dam age to a, PI, these
additions should have an impact on the ACT-mediated dam age to a, PI.
Addition of SOD, by the multiple addition protocol, to incubations of a,PI
with ACT had no effect on the loss of a,PI activity. The additions of SOD
alone did not affect the EIC of a, PI.
3 . 1,3 Discussion.
3 .1 .3 .1

The effect o f antioxidant en zym es on the A C T m ediated damage

to a,Pi. The activity of catalase is compromised by ACT, hence the use of
relatively low concentrations of catalase fail to provide more than ca. 50%
protection. The reasons for this loss of activity are unknown, and the
mechanism could be complex, given the number of com ponents present in
ACT. However, at least one explanation could be the continual exposure
of catalase to ACT-derived hydrogen peroxide and reducing species
(including superoxide). Such exposure could lead to the generation of
catalytically inactive forms of catalase, such as com pound II or III
(198,199). Also, the low concentrations of catalase could fail to provide

92
Table 21.

The activity of SOD added by multiple addition to ACT.

Incubation

% Reduction"

Control SOD, 3 h

18 ±

SOD + ACT, 3 h

75 ± 1

Control SOD, 7 h

10

SOD + ACT, 7 h

58 ± 2

Control SOD, 11 h

8

±

±

2

2

1

SOD + ACT, 11 h

46 ± 4

Control SOD, 24 h

3 ± 3

SOD + ACT, 24 h

36 ± 4

a - Mean ± av.dev. of tw o ACT preparations.
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adequate protection because of the high Km of catalase for hydrogen
peroxide (200). Since hydrogen peroxide is produced in relatively small
quantities in ACT (see section 3.2), the low concentrations of catalase
could fail to outcom pete the a, Pi-damaging reactions d epen d ent on
hydrogen peroxide. Maintenance of catalatic activity w as achieved by
several timed additions of catalase to incubations. As a result of the
substantial protective effect of catalase, hydrogen peroxide appears to be
an essential com ponent of ACT-mediated dam age to o,PI. Organic
hydroperoxides could be responsible for som e o,PI dam age, since catalase
may use alkyl and acyl hydroperoxides as substrates (200). However, the
predominance of hydroxyl radical adducts and apparent ab sen ce of alkoxyl
radical add ucts in spin-trapping studies suggest th a t hydrogen peroxide is
the major hydroperoxide in ACT (22). Hydrogen peroxide is also thought to
be involved in dam age to o,PI caused by aqueous extracts of gas phase
cigarette smoke (130).
Particulate phase smoke is reducing relative to th e gas phase, yet
cigarette smoke can oxidize various chemical species. The oxidative ability
of smoke is achieved primarily by the products of dioxygen reduction
(18,201-203). The generation of hydrogen peroxide in ACT has been
dem onstrated, and probably arises mainly from superoxide formed during
autoxidation of polyphenols (particularly hydroquinone and catechol)
present in the extracts (22-25).
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There are a multitude of reactions th a t can occur involving the
autoxidation of polyphenols and the generation of reactive oxygen species.
Some probable reactions are illustrated in equations 16 to 24: QH2, GH‘,
quinol; Q*"( semiquinone; Q, quinone; M, transition metal complex. Many
of th ese reactions could occur within the context of a "polymeric quinone
matrix” as h as been suggested by ESR studies on cigarette tar (18,21).
QH2 y

QH~ + H*

(16)

QH' + M°4 ------> O ' + H*+ M<n'1l+

(17)

M,n1,+ + 0 2 ^

(18)

Q*- + 0 2 ^

^ M"* + 0 2*'
^ Q + 0 2*-

(19)

H 0 2* + H+ + 0 2*- ------------ > H 20 2 + 0 2 (20)
M'"1,+ + H20 2
2Q*‘ + 2H* ^

> M " + + HO* + HO* (21)
> QH2 + Q

(22)

QH2 + 0 2* " ^ - TQ*~ + H20 2

(23)

Q*“ + Mn+

(24)

^ Q +

The partial protection show n by heat-denatured catalase indicates
that a portion of the protective ability of native catalase may be due to
non-specific scavenging of damaging species. Mild protection of a, PI by
5 mg/ml (75 j/M) BSA is consistent with scavenging of damaging species
by proteins at sufficiently high concentration. The reasons for this
protective action are likely to include sacrificial oxidation of susceptible
amino acid residues, such as Cys and Met if they are accessible to oxidants
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(however, se e section 3.2.3.21. The single Cys-SH group of BSA is known
to undergo oxidation to the sutfenic acid and higher oxidation s ta te s upon
exposure to hydrogen peroxide (204,205). By comparison, 1 mM free Cys
(Table

8

) poorly protects, thus the approximately 75 y M Cys-SH in BSA is

expected to be even less protective. However, the sterically isolated BSA
Cys-SH is probably less prone to autoxidize and thus may provide more
effective scavenging of oxidants com pared to a similar am ount of free thiol
(section 3 .1 .3.3).
Albumin (and other proteins) in lung lining fluid could provide a
protective function in lung ELF by competing for protein damaging species
with more critical targets. Albumins have been proposed to serve an
antioxidant function in serum (206,207). The antioxidant function of
serum proteins may extend to ELF since som e serum proteins are likely to
have increased concentrations in sm okers' lungs, due to cigarette smokeinduced increases in alveolar permeability (207-209).
Earlier studies show ed th at SOD could diminish hydrogen peroxide
production in ACT (23). Some other studies concerning whole smoke
show ed that SOD had only minimal effects on the sm oke dam age to o,PI
(135). The results reported in section 3 .1 .2 .4 show th a t even if SOD
decreases hydrogen peroxide levels in ACT this has no effect on ACT
dam age to o^PI as m easured in these studies.
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The results in section 3 .1 .2 . 6 sh ow that SOD is sensitive to w ater
soluble cigarette sm oke com ponents and/or species derived from them.
This sensitivity of SOD is apparently greater than that show n by either
catalase or a, PI. Comparing th e dam age by ACT to the three proteins
studied: 2 .4 //M a,PI lost ~ 8 0 % activity in 2 4 h; 2.1 j/M catalase lost ~
4 0 % activity in 4 h; 1.6

SOD lost — 60% activity in 1 h. Although

hydrogen peroxide has been reported to inactivate copper,zinc-SOD
(210,211), th e loss of SOD activity in ACT w as apparently not related to
hydrogen peroxide since catalase did not protect (section 3 .1 .2 .6 ). One
possibility is that since a, PI exposed to cigarette smoke in vitro becom es
more anionic [this dissertation and refs (134,212) ], the sam e could happen
to SOD thus interfering with the electrostatic guidance mechanism crucial
to the activity of SOD (213).
3 . 1.3.2 The effect of free amino acids on the A C T m ediated dam age to
a,Pl. The protective ability of free amino acids tow ard ^ P l w a s tested in
earlier studies on gas phase smoke dam age to o,PI (130). The amino acid
protection studies could provide some information on the amino acid
residues in a,PI th at are targets of cigarette sm oke dam age. The effects of
eleven L-amino acids w ere tested which w ere selected for either
dem onstrated susceptibility to oxidative attack (Pro, Met, Phe, His, Trp and
Cys) (214,215) or involvement in the proteinase inhibitory activity of a,PI
(Met, Ser, Arg, Lys) (51,216-218). Alanine w as chosen as an unreactive
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aliphatic amino acid, to te st th e protective effect of the o-carboxyl and aamino groups.
The results (Table

8

) Imply that the nature of th e damaging species

in gas-phase cigarette smoke and ACT sh ow som e differences. The
protective action of the unprotonated amine group in gas p hase smoke
exposures of a,PI is not found for ACT (130). Amines probably protect
a, PI exposed to gas phase smoke because modification of the e-amino
group of Lys residues in o,PI results in loss of EIC (216,217). Direct
exposure of o^PI to gas phase cigarette smoke results in a fast and slow
phase of inactivation [Fig 2, and Ref. 188], amines protect equally well in
both phases, probably by different m echanism s (130). Protection from fast
phase EIC loss w as proposed to arise by interception of peroxynitrates by
am ines (130): authentic peroxynitrates mimic the fast phase of EIC loss by
o,PI exposed directly to cigarette smoke (219). Also, carbonyls in cigarette
sm oke may react with Lys residues to generate Schiff's bases, and
cigarette smoke can modify protein amine groups by generating
cyanomethyl derivatives (2 12 ,2 20 ,22 1). Amines may protect o,PI from
th e slow phase of EIC loss due to gas phase smoke exposure by sacrificial
oxidation and formation of cyanomethyl derivatives. However, it is unlikely
that amines protect in gas phase smoke exposures by scavenging hydrogen
peroxide (see section 3.2.3 .2 ). A previously unconsidered mechanism for
amine protection in th e slow phase is nucleophilic attack on quinones
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generated in smoke solution (polyhydroxybenzenes are abundant in
cigarette sm oke, se e Chapter 1), th ese quinones could modify susceptible
amine groups in o,PI (222,223).
Methionine and methionine sulfoxide protect o,PI equally from gas
phase cigarette smoke dam age (130), but only Met protects in ACT (Table
11). The protective action of Met su g g ests that oxidation of Met in a,PI
could contribute to ACT-mediated EIC loss, which is reasonable given the
significant loss of EIC w hen the reactive center Met 368 of o,PI is oxidized
(see Chapter 1). Oxidation of Met to the sulfoxide by ACT is supported by
amino acid analyses (sections 3.2.2.1 & 4.1.2) and the fact th a t 10 mM
MetSO does not protect o,PI against ACT dam age (Table 11). The effect
of Cys on ACT-mediated dam age to o,PI is discussed in section 3 .1 .3 .3 .
3 .1 .3 .3

The effect o f hydroxyl radical scaven gers and reducing sp ecies on

the A C T m ediated dam age to a,Pi. The data so far sug gest that hydrogen
peroxide is an important com ponent of the mechanism by which ACT
dam ages o,PI. However, it is uncertain w hether hydrogen peroxide is the
damaging species p er se, hydrogen peroxide could be involved in
generation of the ultimate damaging agents(s). Since hydrogen peroxide
could be a source of more reactive oxidants, such as hydroxyl radicals, the
authentic hydroxyl radical scavengers, benzoate and mannitol, w ere tested
for protective effects on ACT mediated a,PI dam age. The data (Table 12)
show no protection by hydroxyl radical scavengers, suggesting that
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hydroxyl radicals generated in ACT do not affect the EIC of a,PI. However,
in "cleaner chemical system s" a^PI is dam aged by hydroxyl radicals (224).
Hydroxyl radicals have been detected in ACT by spin-trapping studies (22)
and have been proposed to contribute to DNA dam age (33) and to the
oxidizing capacity of smoke solutions (135). However, the high reactivity
of hydroxyl radicals su g g ests they could be effectively scavenged by more
abundant ACT com ponents before reaching critical sites on a, PI. The data
would be consistent with reactive oxygen species (ROS) generated sitespecifically on ^ P l (where scavengers have poor access) being responsible
for som e of the dam age to a,PI in ACT (225). Hydroxyl radical scavengers
have been dem onstrated to react with hydroxyl radicals generated in ACT
(22). Thus, dam age to a,PI by radicals derived from scavengers could be
another explanation for the lack of protection by mannitol and benzoate.
However, previous studies have show n th a t alkyl, alkoxyl and peroxyl
radicals do not affect the EIC of o,PI (219). The lack of protection by
mannitol and serine (Tables 11 & 12) imply that homogeneously generated
hypervalent metal species, such as ferryl, are not involved in dam age to
o,PI by ACT (226,227).
Ascorbate and the thiols could exert their protective action in ACT
by several mechanisms. The direct reaction of thiols with hydrogen
peroxide has been determined to be slow (205,228), but over the extended
incubation times used in the studies with ACT direct reaction could be of
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som e importance. Since ascorbate and th e thiols are effective reducing
ag en ts they could reduce adventitious transition metal ions in ACT which
could th en participate in the Fenton reaction, to decom p ose hydrogen
peroxide to more reactive species, such as hydroxyl radicals. Even though
the incubation buffer is treated with Chelex*-100, adventitious transition
metal ions are likely to be present (229); th e cigarettes will also supply
transition metals (6). The incubations w ere performed under air, therefore
oxygen is likely to com pete very effectively with hydrogen peroxide for
reduced transition metals. As discussed below, ascorbate and the thiols
could autoxidize in ACT and deplete oxygen in the closed vial incubations;
the decomposition of hydrogen peroxide by Fenton reactions would
therefore be more pronounced during the later stag es of the incubations.
The oxygen content of the closed vials is sufficient to support
autoxidation of ascorbate and thiols. Autoxidation will not only deplete
oxygen in the vials, but will decrease the concentration of reducing groups
and generate ROS (230). Clearly (Table 12) under closed vial incubations
the protective abilities of ascorbate and thiols at 10 mM predominate over
any contribution their autoxidation may make to th e loss of a, PI activity by
generation of ROS, or their potential to regenerate autoxidizable ACT
com ponents such as hydroquinones (223). The protective action of
ascorb ate and the thiols at 1 mM is negligible (Table 12), probably due to a
combination of exhaustion of reducing ability through autoxidation and
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poorer competition with a,PI for oxidants. The minimal protective ability of
GSSG (Table 12) dem onstrates that the sulfhydryl group of GSH is
responsible for the protective action of this com pound.
In air-purged incubations the protective abilities of th e reducing
ag en ts are noticeably different (Table 13), the order of a,PI protection is:
Met ~ thiourea > GSH > ascorbate — Cys > DTT, This order of
protection can be explained by the differing autoxidation properties of the
various com pounds. Thiourea and Met likely autoxidize the slow est, Cys
autoxidizes faster than GSH, and DTT autoxidizes faster than both of the
monothiols (231). Under continual air-purging, th e differing degrees of
autoxidation of the protective species will generate differing quantities of
ROS and at the sam e time deplete differing am ounts of protective groups.
Thiourea, like Met, protects at both 1 and 10 mM, which is probably
due to slower autoxidation and the dem onstrated ability of thiourea to react
directly with hydrogen peroxide (232-234). The hydroxyl radical
scavenging and metal complexing properties of all of the reducing species
probably contributes minimally to their protective ability in ACT, since
benzoate, mannitol and high concentrations of potent metal complexing
agents fail to provide more than 50% protection (Tables 12 and 14). Even
though thiols, ascorbate and thiourea have been reported to react with
superoxide (235-237), such reactions are probably unimportant for
protection of ^ P l against dam age by ACT.
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Data to be presented later indicate that MetSO formation in a, PI
exposed to ACT is the probable explanation for the EIC loss. Thiols, at
high concentrations, long (> 15 h) incubation times and often high
tem perature (> 50 *C), are able to reduce MetSO to Met (238). Since long
incubation times are used in the ACT studies and the reducing agent:o,Pi
molar ratio is about 4000:1 (10 mM reducing species), the protective
effect of thiols could partly be due to "repair" of oxidized cr,PI. Such a
repair action may also be feasible for ascorbate and free methionine (239).
3 .1 .3 .4

The effect o f chelators on the A C T m ediated dam age to o,P/.

Metals in ACT could participate in dam age to o,Pl in several w ays. More
reactive oxidants (such as hydroxyl radicals or hypervalent transition metal
species) could be generated from reactions of transition metals with
hydrogen peroxide (226). The a, PI could be dam aged site-specifically by
the interaction of hydrogen peroxide with transition metal-o^PI complexes
(225). Also, transition metals are likely to be catalysts of polyphenol
autoxidation and subsequent generation of hydrogen peroxide (230). In
ACT all of th e se factors may be involved to differing extents in the actions
of the various chelators tested. As noted earlier, adventitious transition
metals are likely to be present in the incubation buffer, and the cigarettes
may provide a maximum of 0.5 gM iron and copper in ACT (6,229).
Chelators only exert effects in ACT at high concentrations, this could be
due partly to competition betw een added chelators and chelators in ACT
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[e.g. polyphenols). However, other factors such as limiting concentrations
of transition metal ions and reducing species could also be im portant.
Previous studies dem onstrate that 30 mM EDTA added to ACT
results In an approximately 16*fold increase in the hydroxyl radical/spin-trap
adduct signal (22). This increase in hydroxyl radical flux w as proposed to
occur via a metal catalyzed Haber-Weiss reaction (equations 18 and 21
below), although quinol/semiquinone driven Fenton reactions could also be
involved (equations 17, 18, 21 and 24, below} (22,33,34).

M
j. H j 0 2— > Mn+ + H0« + HO'
QH_ + Mn+
Mn +

> Q*" + H+ +
I Z ± Q + Mlr“1,+

(18)
(2 1 )

(17)
(24)

In the absence of EDTA, hydroxyl radical spin adduct signals in ACT
are low (22). Thus, transition metal-ACT com ponent com plexes cause
minimal hydrogen peroxide decomposition, or EDTA serves to transfer
hydroxyl radical generation to locations accessible to the spin-trap. Unlike
EDTA, 30 mM DTPA abolishes hydroxyl radical spin-adduct signals in ACT
(22). Thus it has been concluded that metal catalyzed Haber-Weiss or
quinol/semiquinone driven Fenton reactions are not supported by DTPAbound metals in ACT (22). Protection by DTPA (Table 14) could therefore
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occur by inhibition of transition metal-catalyzed polyphenol autoxidation
and/or the removal of protein-bound metals from sensitive sites on a,PI. In
addition to th e m echanism s noted for DTPA, EDTA probably protects a.,PI
by degrading hydrogen peroxide to more reactive and less selective ROS
via an EDTA-metal ion complex. The failure of benzoate to improve the
protective effect of EDTA su g g ests that hydroxyl radical generation by
EDTA-metal com plexes does not compromise the protective effects of
EDTA.
It is unlikely that DTPA or EDTA protect by the direct scavenging of
OjPI-damaging species. Firstly, additives that would be considered more
effective scavengers of a, Pl-damaging agents (Lys, His, Trp and Pro for
example) do not protect o,PI from ACT dam age (Table 11). Secondly,
EGTA and HIMDA, which are structurally similar to DTPA and EDTA but
less effective chelators of transition metals, show poorer protective ability
(Table 14).
Ferric ions added to ACT show som e protection of a,PI (Table 14),
probably via the degradation of hydrogen peroxide by an iron-ACT
com ponent complex. The addition of ferric chloride to cigarette smoke
solutions has been show n to increase the decomposition of hydrogen
peroxide to more reactive species (25). The fact that benzoate does not
enhance protection by ferric ions (Table 14) su g g ests that the protective
effects of ferric ions are not compromised by an increased flux of free
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hydroxyl radicals. Other factors, such as binding of ferric ions to or,PI, may
negate som e of the protective potential of the ferric ions.
In contrast to EDTA and DTPA, Desferal* did not protect a, PI (Table
14), which could indicate that ferric ions are not involved in ACT dam age
to a,PI. However, th e effects of Desferal* in ACT would be expected to be
similar to the effects of DTPA, i.e. the inhibition of both th e decomposition
and generation of hydrogen peroxide. Some studies have show n that 0 .5
mM Desferal* inhibits the generation of ROS in cigarette sm oke solutions
(25). Any protective actions of Desferal* could be compromised by
reaction with superoxide in ACT to produce a protein damaging nitroxide
radical (240,241).
Copper has received particular attention with regard to site-specific
dam age to proteins including a,PI (242-245), and could feasibly be involved
in or, PI dam age by ACT. Both DTPA and EDTA are reasonable cupric ion
chelators [log stability con stan ts for Cu (II) of 2 1 .4 and 18.8 respectively
(246) ], thus their effects could also be explained on the basis of copper
complexation. The most protective of all the chelators studied is DDC
(Table 14), which b ecau se of its structural similarity to thiourea is likely to
protect mostly by sacrificial oxidation rather than copper complexation.
Bathocuproine disulfonate, a chelator of cuprous ions, does not protect a, PI
(Table 14).
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Since EDTA, DTPA, Desferal* and histidine w ere all unable to protect
a, PI from dam age by ACT, then site-specific dam age to critical residues in
a, PI by metal catalyzed ROS generation seem s unlikely or plays a minor
role (2 25,247-249). Although, if multiple m echanisms operate in ACT to
dam age a, PI, all of which are dependent on hydrogen peroxide, then
elimination of any one mechanism will not prevent the loss of EIC.

2x2 Modelling Aqueous Cigarette Tar Extract-Mediated Damage to o TPI.
The overall aim of the studies in this section w as to model ACTmediated EIC loss of a, PI using simpler system s. Much of the data
reported so far implies that the dam age to o,PI by ACT contains a
substantial oxidative com ponent, dependent on hydrogen peroxide. The
studies in this section are designed to determine w hether or not hydrogen
peroxide p e r se could be responsible for m ost of the EIC loss of or, PI
exposed to ACT.
Studies on ACT/hydrogen peroxide combinations w ere performed to
detect any synergism betw een ACT com ponents and hydrogen peroxide.
Incubations of a, PI with ACT under low oxygen tensions a ssessed the
importance of oxygen in the ACT damaging mechanism.
The above experiments depended on reasonable estim ates of the
am ount of hydrogen peroxide generated by ACT. Some previous studies
were helpful in estimating hydrogen peroxide formation in ACT (23).
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However, there are som e difficulties in using the data from th e earlier study
(23) and experim ents reported in this section of the dissertation were
designed to address th e se difficulties. Since a preliminary study indicated
th a t MetSO w as the product of ACT-methionine interaction, experiments
w ere geared tow ard detection and quantitation of MetSO. The quantitative
d ata could be used to estim ate th e oxidative capacity of ACT tow ard Met.
As will be noted in section 3 .2 .2 the hydrogen peroxide exposures
sh ow responses to protective species similar to th o se observed for the ACT
exposures. Hydrogen peroxide exposures adequately account for MetSO
formation in fl^PI exposed to ACT (section 4.1), but do not reproduce the
ACT-damage to o,PI in terms of changes in electrophoretic mobility (section
4.2). Studies using catechol/hydroquinone may provide a better model for
ACT dam age to a,PI, since the quinols provide oxidants and are reducing
species, a situation more akin to ACT.
3 .2 .1 Experimental.
3 .2 .1 .1 Estimation o f the oxidizing capacity o f ACT: A n alyses o f
methionine, methionine sulfoxide and valine ex p o sed to ACT. Incubations
of 5 0 0 pL total volume were performed under the standard conditions in

1

mL Eppendorf vials. Control incubations of 15.6 mM Val + 8 .4 mM
MetSO or 1 6.4 mM Val + 1 1 . 8 mM Met w ere done in incubation buffer
only. After 24 h incubation the samples w ere frozen and lyophilized.
Following Iyophili2 ation the residues were dissolved in 1 mL of 0 .4 N boric

108

acid, pH 10.2 and diluted 1/100 with the sam e buffer. The sam ples w ere
then filtered through individual filter syringes (LID/X filter syringes, 0 .4 5
//m, nylon - 6 6 filter; Xydex Corp., Bedford, MA) and the filtrate transferred
to HPLC vials.
The HPLC analyses w ere performed on a Hewlett-Packard, HP 1090
liquid chrom atograph equipped with a diode array detector, ternary solvent
delivery system , variable-volume auto-injector, auto-sampler,
thermostatically controlled column com partm ent and a 2 0 0 x 2.1 mm, 5 p,
Hypersil OOS microbore amino acid analysis column (Hewlett-Packard, Palo
Alto, CA). Samples were subjected to an on-line pre-column derivatization
procedure, using an injection program, with 25 mM mercaptopropionic acid
and 25 mM o-phthaldialdehyde prior to injection (250I. Injections of 26 pL
w ere made, containing 5 pL of sample solution mixed with 0 .4 N borate,
pH 10.2 and the derivatizing agents. Analyses w ere performed at 35 °C
and the chromophore w as detected at 338 nm. The mobile phase w as
com posed of a binary solvent system : solvent A, 20 mM sodium acetate,
pH 7.2, containing 0.1 mM EDTA, 0 .5 % v/v tetrahydrofuran and 0 .0 1 5 %
v/v triethylamine; solvent B, 8 0 % v/v acetonitrile/20% v/v 0.1 M sodium
acetate. Solvent A w as decreased non-linearly from 98% to 0 % over 15
min, at a flow rate of 0 .4 4 mL/min (250). Calibration curves w ere
constructed using 5, 50 and 100 pM standards containing a mixture of
valine, methionine and MetSO. The chrom atogram s w ere processed using
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softw are supplied with the HPLC system .
3 .2 .1 .2 The effect o f hydrogen peroxide a t concentrations relevant to
th ose produ ced in A C T on the activity o f a,Pi. The effect of hydrogen
peroxide alone on the EIC of a^PI w as determined by incubating 1.3 mM
hydrogen peroxide with 125 p Q / m L o,PI under the standard conditions.
Hydrogen peroxide w as added as three aliquots, 5, 5 and 10//L of an 20 mM stock at 0, 4 and

6

h, to give concentrations of 0 .3 3 , 0 .6 6 and 1.3

mM hydrogen peroxide respectively. The final incubation volume w as 315
pL. This repetitive addition protocol w as adopted to avoid exposing a,PI to
hydrogen peroxide in one step.
A time course of the loss of EIC of a,PI exposed to 1.3 mM
hydrogen peroxide by th e multiple addition protocol w as constructed by
simply determining th e EIC at selected time points. The effects of som e of
th e additives that protected in ACT were also tested in this cleaner
hydrogen peroxide system , In all ca ses incubations w ere under the
standard conditions, using hydrogen peroxide at 1.3 mM added according
to the protocol described in the above paragraph.
3 .2 .1 .3 The effect o f ACT/hydrogen peroxide com binations, and ACT
under io w oxygen tension, on E/C foss o f a,Pi. Studies on th e interaction
of hydrogen peroxide with ACT com ponents involved exposures of 125
P Q / m L a,PI to ACT for 24 h under normal or low oxygen tensions in the

presence of 0 .9 mM hydrogen peroxide. Hydrogen peroxide w as added as
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three aliquots, 5, 5 and 1 0 //L of an 18.5 mM stock a t 0, 4 and

6

h, to

give concentrations of 0 .2 3 , 0 .4 6 and 0 .8 9 mM hydrogen peroxide
respectively. The final incubation volume w a s 4 1 5 //L. Also, 4 hr
incubations of or, PI with hydrogen peroxide and ACT w ere performed;
hydrogen peroxide w as added at the start of the experim ent to give a
concentration of 0 .4 mM in a 4 0 0 /sL incubation volume. In all cases
w here hydrogen peroxide solutions were added over time, control
incubations received equal volumes of deionized w ater. Incubations under
low oxygen tensions w ere continuously purged with argon, w hereas
incubations under normal oxygen tensions w ere continuously purged with
air (see section 3.1.2.2).
3 .2 .1 .4 Catechol and hydroquinone as a m odel for the effects o f A C T on
a,PI. Alpha,PI at 125 //g/ml w as exposed to 2 3 0 fjM catechol and
2 3 0 ^M hydroquinone, the exposures also contained 0.1 |/M Fe(ill) and
0 .3 #/M Cu(ll). The catechol and hydroquinone stocks w ere prepared fresh
at the start of every experiment. The incubations w ere done under the
standard conditions and the EIC determined after 2 4 h. The time course of
the loss of EIC of a,PI exposed to catechol/hydroquinone w as simply
determined by assessing EIC at selected time points. In some ca se s
additives w ere used to asse ss protective effects tow ard o,Pt exposed to
the catechol/hydroquinone mixture.
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3.2,2 Results,
3 .2 .2 .1 Estimation o f the oxidizing capacity o f ACT: A n alyses o f
methionine, methionine sulfoxide and valine ex p o sed to ACT. The data
from this experiment are presented in Table 22. When Met is incubated
with ACT under the standard conditions, MetSO, and not methionine
sulfone, is produced. The ACT contains no species th a t are detectable by
the amino acid analysis procedure, as determined w hen only ACT is
injected into the HPLC. The production of MetSO can be used to estim ate
the oxidizing capacity of ACT tow ard Met. After 24 h, 1.28 jt/moles of Met
are oxidized to MetSO/ml ACT (Table 22).
The negligible change in Vat and MetSO concentrations after
exposure to ACT (Table 22) suggests that ACT has little affect on the
integrity of the or-amino or carboxyl groups. Since only about 6 0 % of the
d ecrease in Met content after exposure to ACT is accounted for by the
increase in MetSO (Table 22), a portion of Met is depleted in ACT by
uncharacterized pathw ays. If ACT were able to reduce MetSO to
methionine, this could lead to an underestimation of th e oxidizing capacity
of ACT; however, incubation of MetSO with ACT for 24 h does not result
in the measurable formation of Met (Table 22).
3 .2 .2 .2 The effect o f hydrogen peroxide a/one, and in combination with
ACT, on the activity o f a,Pi. Under low oxygen tensions, a,PI activity is
unaffected by ACT (Table 23). Co-incubation of ACT and 0 .9 mM hydrogen
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Table 2 2 .

A nalysis o f M et, M etSO and Val e x p o se d to ACT.

% change in
concentration*

Incubation"
Val

Met

MetSO"

Val + Met +
ACT

- 1.5
± 0 .3

- 18.9 ±
1.4

+ 11.1
± 0 .2

Val + MetSO +
ACT

+ 3.1
± 0 .1

N.D.*

- 0 .6 ±
0 .3

l/mol MetSO
formed
0 .6 4 ± 0 .0 2 -

a - See Experimental.
b - After 2 4 h, relative to amino acids incubated in buffer only:
+ , indicates increase; indicates decrease. Mean ± s.d. of three ACT
preparations,
c - As a percentage of initial Met concentration,
d - Mean ± s.d. for 3 ACT preparations,
e - Not detected.
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Tabla 23. The effect of ACT and hydrogen peroxide alone and in
combination under normal and low oxygen tensions on the EIC of a,PI.

Exposure

[0 2]

Time, h*

% EICfc

ACT

Normal

24

15 ± 4 “

ACT

Low-

24

9 6 ± 4"

ACT

Normal

4

70 ± 3

ACT

Low

4

Normal

4

55 ± 4

ACT + 0 .4 mM H20 2

Low

4

87 ± 3

ACT + 0 .9 mM H2 0 2

Normal

24

0

ACT + 0 .9 mM H20 2

Low

24

35 ± 2

0 .4 mM H20 2

Normal

4

9 4 ± 3*

0 .9 mM H20 2

Normal

24

33 ±

1.2 mM H20 2

Normal

24

42 ± 41

1.3 mM H20

Normal

24

33 ± 14"

ACT + 0 .4 mM H20

2

2

±

102

2

6

*

a - Incubation time.
b - Unless indicated, data are means ± s.d. of three separate ACT
preparations,
c - Five separate ACT preparations,
d - Flushed continually with argon; se e Experimental,
e - Six ACT preparations,
f - Five ACT preparations,
g - Seven ACT preparations.
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peroxide leads to abolition of EIC after 2 4 h under normal oxygen tensions,
but not under low oxygen tensions (Table 23). Some data w ere obtained at
4 h incubation to study further the synergistic interactions betw een ACT and
hydrogen peroxide. Under normal oxygen tensions, ACT
en han ces the damaging effects of 0 .4 mM hydrogen peroxide (Table 23).
However, under low oxygen tensions ACT only minimally increases the
dam age to a,PI by 0 .4 mM hydrogen peroxide (Table 23).
Data for the effects of additives on the activity of a,PI exposed to 1.3
mM hydrogen peroxide are presented in Table 24. The percent protection
values w ere calculated according to equations 4 and 5 in section 3.1, with
"hydrogen peroxide" substituted for "ACT" in th ese equations. Figure

6

sh o w s a time course of the loss of EIC of a,PI exposed to 1.3 mM hydrogen
peroxide added by the multiple addition protocol.
3 .2 .2 .3 Catechol and hydroquinone as a m odel for the effects o f A C T on
a,PL The concentrations of catechol, hydroquinone, Fe(lll) and Cu(ll) used
for the exposures of or, PI w ere calculated according to th e levels of these
species found in 1R1 cigarettes:
Fe: 0 .0 4 2 //g/cig.
Cu: 0 .1 9 //g/cig.
Catechol: 110-300 /yg/cig.
Hydroquinone: 100-300 //g/cig. (12).

115
Table 2 4 . The e ffe c t o f varioua com p ou n d s on th e activity o f o,PI e x p o se d
to 1 .3 mM hydrogen peroxide.

Additive*

% Protection*

Ascorbate

93 ± 3

Thiourea

97 ± 2

Methionine

92 ± 3

DDC

94 ± 1

DTPA

-2 ± 3

50 mM Benzoate

- 2 ± 3

EDTA

7 ± 3

EDTA + 50 mM Benzoate

10 ± 1

5 mg/mL BSA

- 10 ± 10

GSH

97 ± 3

Ala

- 10 ± 2

a - All at 10 mM unless indicated otherwise,
b - Mean ± av.dev. for tw o independent runs.
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Figure 6 . Time course of the EIC loss of 125^/g/ml o^PI exposed to 1.3 mM
hydrogen peroxide. The hydrogen peroxide w as added at three times (see
Experimental).
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The concentrations used in the exposures assum e com plete
extraction of all four species (250 //g/cig. for each of the
dihydroxybenzenes) into ACT, thus the exposures represent upper levels. In
hindsight, the addition of the transition metals w as perhaps pointless, as
phosphate is the most abundant complexing agent in the incubations
(100 mM).
AlphajPI exposed to catechol/hydroquinone [plus Fe(lll)/Cu(ll)]
retained 47 ±

6

% EIC (mean ± s.d.; 9 separate incubations). Omission of

the Fe(lll) and Cu(ll) resulted in the retention of a further 10 ±

1

% EIC

(mean ± av.dev.; 2 separate incubations). The data concerning the effects
of various species tested for protective ability are presented in Table 25.
Figure 7 show s a time course of the loss of EIC of a, PI exposed to
the catechol/hydroquinone system . The rate of loss of EIC is comparable to
that of the hydrogen peroxide and ACT exposures.
3 - 2, 3 Discussion.
3 .2 .3 .1 Estimation o f the oxidizing capacity o f ACT. If hydrogen peroxide
is the primary oxidant of Met in ACT, then MetSO formation can be used to
estim ate th e hydrogen peroxide content of ACT. Peroxides oxidize sulfides
with a 1:1 stoichiometry (251), thus data on Met oxidation show n in Table
22 would indicate the formation of 0 .6 4 ± 0 .0 2 //moles of hydrogen
peroxide in the ACT incubations {i.e. 1.28 ± 0 .0 4 mM hydrogen peroxide).
A previous study has quantitated hydrogen peroxide production in ACT (23),
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Table 2 5 . The e ffe c t o f various com p ou n d s on th e activity o f fffPI e x p o se d
to 2 3 0 f / M c a te ch o l, 2 3 0 //M hydroquinone*.

Exposure

% Protection*

10 mM Thiourea

54 ± 1

10 mM Methionine

96 ± 4

10 mM DTP A

- 5 ± 5

10 mM GSH

94 ± 2

5 mg/ml BSA

92 ± 4

5 0 mM Benzoate

- 16 ±

1

10 mM Methionine sulfoxide

59 ± 1

10 mM Methionine sulfone

65 ± 1

10 mM Ala

69 ± 3

a - Plus 0.1 fiM Fe(lll) and 0.3 fjM Cu(ll).
b - Mean ± av.dev. for 2 runs.
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Figure 7. Time course of the loss of EIC of 125 //g/ml crtPI exposed to
230 /sM catechol/230 /sM hydroquinone.
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but depending on how the data are interpreted, different quantities of
hydrogen peroxide can be calculated to have formed in 2 4 h. If w e assum e
there is no turnover of hydrogen peroxide in ACT then after 2 4 h, 0 .8 4 ±
0.21 mM hydrogen peroxide would be calculated to be present. On the
other hand, if th e hydrogen peroxide is continually generated and destroyed,
then a minimum of 2 .8 6 ± 0 .2 4 mM hydrogen peroxide would be estimated
to form in ACT.
It w as noted in section 3.2.2.1 that only about 60% of the Met w as
detected as MetSO. The remaining 4 0 % is unaccounted for and at least
tw o possibilities for the fate of this 4 0 % can be ruled out: Met w as not
oxidized to methionine sulfone as this would have been d etected by HPLC;
modification of the a-amino or carboxyl groups is unlikely, since Val
underw ent no overall change. Underestimation of the am ount of hydrogen
peroxide in ACT would have little impact on the studies of dam age to a, PI,
since higher levels of hydrogen peroxide would incur even greater dam age
than that observed in the studies presented in section 3 .2 .2 .2 . Reduction of
MetSO to Met by ACT is undetectable, thus ruling out one possible reason
for underestimation.
Gross overestimation of the hydrogen peroxide con ten t of ACT by the
Met oxidation method is more troublesome. A major contributor to
overestimation would be a lack of specificity of Met oxidation. Most of the
oxidizing capability of cigarette smoke solutions is ultimately attributable to
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hydrogen peroxide (25). Hydroxyl radical is an obvious candidate as a Met
oxidant since this has been su gg ested to contribute to th e oxidizing capacity
of cigarette sm oke extracts, and hydroxyl radical can oxidize Met to the
sulfoxide (135,252). Since the data of Nakayama ef at. (23) indicate 0 .8 4
± 0 . 2 1 mM as a lower level for hydrogen peroxide concentration in ACT,
the value of 1.28 mM suggested by the Met oxidation data does not seem
unreasonable.
3 .2 .3 .2 Hydrogen peroxide and a fP(. If hydrogen peroxide can act alone in
ACT to dam age o,PI, then a concentration of hydrogen peroxide equal to
that formed in ACT over 24 h should depress a,PI activity to a similar extent
to that seen for ACT. The data (section 3 .2.2.2) su gg est hydrogen
peroxide could account for most of the dam age to a, PI caused by ACT. The
time course (Fig.

6

) show s that th e rate of EIC loss is com parable with ACT-

mediated EIC loss. Earlier (section 2.1.3) it w as sug g ested that damaging
species could accum ulate in aged ACT and the damaging reaction could be
slow. The oxidant quantitation data and the slow ness of EIC loss upon
exposure to hydrogen peroxide supports the idea of the buildup of a slowly
damaging species. Although it seem s reasonable that hydrogen peroxide
could directly dam age o,PI in ACT, the response of a,PI to hydrogen
peroxide is variable, causing about 7 0-80% loss in EIC. Hydrogen peroxide
could account for most of the dam age to a,PI and its damaging effects may
be enhanced by interaction with other ACT com ponents.
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Some synergism is observed betw een the damaging actions of
hydrogen peroxide and ACT. The apparent synergism betw een 0 .9 mM
hydrogen peroxide and ACT is likely due to the additive damaging effect of
the exogenous (i.e. added) and endogenous (i.e. from autoxidation of ACT
com ponents) hydrogen peroxide. Under argon, the loss of EIC due to the
ACT/0.9 mM hydrogen peroxide mixture is attributable to the exogenous
hydrogen peroxide alone. The damaging effect of the ACT/0.4 mM
hydrogen peroxide mixture cannot be explained by the combined action of
exogenous and endogenous hydrogen peroxide, since 0 .4 mM hydrogen
peroxide alone has no effect on the EIC. The incubation of t^PI with
ACT/0.4 mM hydrogen peroxide under argon results in a 13% loss of EIC
Note th at the loss of EIC is 15% greater w hen t^PI is incubated with
ACT/0.4 mM hydrogen peroxide under air as compared to a,PI incubated
under air with ACT alone (Table 23). Thus hydrogen peroxide can synergize
with an unidentified component(s) in ACT to cause enhanced dam age to
o, PI. These data support an earlier suggestion that cigarette sm oke could
enhance the damaging ability of hydrogen peroxide produced from
inflammatory cells in sm okers' lungs (135).
The complete preservation of the EIC of cr,PI incubated with ACT
under argon confirms the previously assum ed d ependence on oxygen of ACT
dam age to o,PI. It is reasonable to conclude that an oxidative mechanism(s)
alone accounts for the loss of EIC of ACT-exposed a,PI.
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The data in Table 23 allow one other point to be addressed, i.e. is
there any difference betw een the rate of EIC loss w hen o,PI is exposed to
ACT in open as opposed to closed incubation vessels? The an sw er is no;
com pare data for 4 and 2 4 h air-purged ACT exposures (Table 23) and the
time course (Fig 1).
Several of the species tested for protective ability in ACT were also
tested in th e hydrogen peroxide exposures. All of the reducing species
protect completely, probably for the sam e reasons noted in section 3 .1 .3 .3
for ACT. The protection by DDC supports the earlier com m ent that it can
act by scavenging oxidants. If the action of DDC w as to remove metals
bound to a,PI then EDTA and DTPA would be expected to exert similar
protection against hydrogen peroxide dam age. Since BSA does not protect
or, PI exposed to hydrogen peroxide, this su g g e sts th e protective role of BSA
in ACT is more than simply by scavenging oxidants. Both EDTA and DTPA
do not protect against hydrogen peroxide dam age to a, PI. Transition metals
play a negligible role in the hydrogen peroxide-mediated dam age to a, PI.
Also, the absence of reducing species implies that Fe(lll)-EDTA, for example,
cannot participate in a radical driven Fenton reaction. Since Ala does not
protect a, PI against hydrogen peroxide dam age, the protective action of the
o-amino group tow ard o,PI in gas phase extract exposures (130) is not due
to sacrificial oxidation by hydrogen peroxide.
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Despite this information it is still not possible to sta te categorically
th a t hydrogen peroxide alone ca u ses the EIC loss of a,PI exposed to ACT,
since hydrogen peroxide could still react with one or more ACT com ponents
to generate th e ultimate damaging species. Such an idea m ust account for
the slow ness of the EIC loss in ACT, e.g. com ponents in ACT that interact
with hydrogen peroxide could be limiting to the production of damaging
species, or th e ultimate damaging species could dam age cr,PI as slowly as
hydrogen peroxide.
The majority of the ACT incubations were performed in closed vials.
Since the damaging mechanism is dependent on oxygen, it seem s prudent to
a s s e s s the oxygen content of the incubation vials. The 500 gL incubation
vials contained 3 0 0 gL of incubate and a 2 0 0 gL headspace.
Air is 2 1 % Oa, and the density of 0 2 = 1.31 mg/ml at 25 °C.
Vol. 0 2 in h eadspace = (21/1001.200 gL = 42 gL.
Weight 42 gL 0 2 = 1.31 gg/gi x 42 gL = 5.5 x 10® g.
MW 0 2 = 32, therefore 5.5 x 10® g = 1.72 x 1 0" mole 0 2.
Molarity of 0

2

in headspace = [(1.72 x 10 ®x 10001/0.2]
=

8 .6

mM

[ 0 2] in w ater at 25 °C = 0 .2 6 mM
Therefore incubation vials contain (8 . 6 + 0.26) - 9 mM 0 2.
The calculation indicates that there is sufficient oxygen present to account
for the estim ated hydrogen peroxide to be produced in ACT.
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As w as noted earlier (section 3.1.3.1 ), much evidence su g g ests that
polyphenols are the major source of hydrogen peroxide in cigarette smoke
solutions. The am ount of autoxidizable species estim ated to be present in
ACT will place a limit on the quantity of hydrogen peroxide th a t could
possibly be generated. Phenols are found at about 0 .6 mg/cig (6 ) in the
particulate phase and if w e assum e complete extraction and an average
molecular weight of
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(dihydroxybenzenes) then w e would estim ate ca.

1.1 mM of th e se species in a 5 0 0 pi incubation of ACT {i.e., as used for the
Met oxidation studies). Since it is highly unlikely that the extraction is
100% efficient, 1.1 mM is an upper estimate. The MetSO formation studies
estim ated at least 1.3 mM "oxidant" in ACT. Therefore there are probably
additional autoxidizable species in ACT and oxidized quinones may be
reduced after autoxidation; e.g., addition of w ater to p-benzoquinone
g enerates further autoxidizable species (223).
3 .2 .3 .3 Catechol/hydroquinone and a fPl. Initially it w a s thought that
exposures of c r, PI to catechol plus hydroquinone would model more closely
the effects of ACT on or, PI than hydrogen peroxide alone. The degree and
rate of EIC loss of or,PI exposed to catechol/hydroquinone is com parable with
that for the hydrogen peroxide exposures (sections 3 .2 .2 .2 & 3). However,
like the hydrogen peroxide exposures the changes in electrophoretic mobility
of catechol/hydroquinone-exposed o,PI did not mimic th o se of ACT-exposed
a,PI (section 4.2.2). Also, the effects of agents tested for protective ability
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w ere noticeably different from their effects in ACT. Overall, the
catechol/hydroquinone system w as a poorer model than the hydrogen
peroxide exposures.
It is likely that catechol/hydroquinone dam ages a,PI by a combination
of lysyl group modification and oxidation (of Met). Since MetSO, methionine
sulfone and Ala protect a,PI by ca. 60% , they all share a common protective
feature. The o-amino group is the probable protective functional group,
m ost likely by nucleophiiic attack on quinones. There is precedent in the
literature for the addition of amines to quinones, and for loss of EIC of a, PI
after modification of lysyl residues (2 16 ,21 7,22 2 ). The higher protective
ability of Met and GSH would be due to both sacrificial oxidation and
reaction with quinones. Also, BSA is very protective and this is likely to be
due to effective competition with a,PI for oxidants and quinones. The lack
of protection by DTPA implies that metal-catalyzed Haber-Weiss reactions
are not involved in the dam age to a, PI. This conclusion is supported to
som e extent by the failure of benzoate to protect. As with the ACT studies
other explanations for the failure of benzoate to protect o r, PI can be invoked,
such as site-specific generation of ROS or hom ogeneous production of ferryi.
Ferric-DTPA complexes, for example, can be reduced by catechols, and
presumably p-hydroxyphenols, and their semiquinones [the slower reaction
of o-semiquinones with oxygen implies th e se would be more effective
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reducing species for Fe(lll) (253) ) thus DTPA is not expected to abolish
polyphenol autoxidation although it may inhibit it (229,253-255).
Although the catechol/hydroquinone system is a poor model with
regard to ACT, the apparent protective effect of amine groups is reminiscent
of gas phase cigarette smoke (GPE) studies (130). Damage to a, PI by gas
phase cigarette sm oke extract is inhibited by unprotonated amine groups and
catalase; hydrogen peroxide w as proposed as a damaging species (130).
Loss of EIC by o,PI exposed to GPE could also involve derivatization of lysyl
residues by formaldehyde/hydrogen cyanide (2 1 2 , 2 2 0 ), carbonyls ( 2 2 1 ) and,
on the basis of the studies presented above, quinones (222). One notable
difference b etw een the dam age due to GPE and catechol/hydroquinone is
that th e former is not inhibited by th e thioether functionality of Met, only the
o-amino group (130).

CHAPTER 4

STRUCTURAL DAMAGE TO a,PI BY AQUEOUS CIGARETTE TAR EXTRACT.

4 J . Amino Acid Analysis of q ,PI Exposed to Aqueous Cigarette Tar Extract
and to Hvdrooen Peroxide.
The cyanogen bromide cleavage technique (256) w as used to study
Met oxidation in o ^ l . This analytical procedure does not interfere with the
detection of other amino acids, apart from glycine, which under the HPLC
conditions employed co-elutes with homoserine generated from the
cyanogen bromide-methionine reaction. This amino acid analysis procedure
w as adopted on the basis of the data already presented, indicating Met
oxidation by ACT, and the established fact of EIC loss associated with
Met 368 oxidation in ^ P l (see Chapter 1). Tryptophan, proline and cysteine
were not determined in these analyses.
4, h 1 Experimental.
Alpha,PI at 125 //g/ml w as exposed to ACT (3.1.1.1) or 1.2 mM
hydrogen peroxide (3.2.1.2). The EIC loss w as determined prior to amino
acid analysis.
The samples w ere filtered through a 1 0 ,0 0 0 nominal molecular
weight limit, low-protein binding, cellulosic membrane filter. The residue
w as then w ashed with 2 x 5 0 0 //I of water, and the w ashed residue
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suspended in 2 1 0 fj\ 70% v/v formic acid. The sam ples in formic acid w ere
transferred to glass screw -cap vials and 100 //I of a 123 mM cyanogen
bromide solution in 70% v/v formic acid w as added. Since cyanogen
bromide is volatile and highly toxic it w as always handled in a fume hood
with extrem e caution. The samples were left to incubate with cyanogen
bromide for 2 4 h at room tem perature. After the 2 4 h incubation, the
sam ples w ere transferred to hydrolysis tubes and th e formic acid removed
under vacuum. To the dried samples 100 fj\ of

6

N hydrochloric acid

(containing 1 . 8 mg/ml DTT) w as added to each hydrolysis tube, the tubes
w ere placed in a hydrolysis vial. Hydrolysis w as done at 110 °C, in vacuo
for 2 4 h. After hydrolysis, the hydrochloric acid w as removed under
vacuum and th e hydrolysate w as suspended with agitation in 300 //I of 0.4N
borate buffer, pH 10.2. The samples were then filtered through individual
filter syringes (0.45 */m, nylon) and the filtrate transferred to HPLC vials.
The amino acid analyses by HPLC w ere performed as described in
3 .2 .1 .1 . Calibration curves were constructed using stan dard s made by
dilutions of a commercially prepared 2.5 mM stock (Pierce Chemical Co.,
Rockford, IL). The chrom atogram s were processed using softw are supplied
with the HP 1 0 9 0 liquid chromatograph system .
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4 . 1 , 2 Results.
The amino acid analysis data for the individual residues are presented
as percentages of the total amino acid co ntent (Table 26). The "Literature"
values were derived by considering data from references 121 and 257-259:
the total number of residues in o,PI w as calculated (excluding Cys, Trp and
Pro) to be 375; the percentage for Gly + homoserine w a s derived using the
sum of the number of Met (which will produce homoserine after reaction
with cyanogen bromide) and Gly residues.
The residue percentages for the native a,PI sam ples agree well with
the literature values. The supplier of the a,PI indicated th at the product
contains < 5 % impurities, but this has negligible impact on the amino acid
analyses. The only explicable difference in the amino acid content of flr,PI
exposed to the tw o treatm ents is the formation of MetSO. The Leu content
of hydrogen peroxide-exposed a, PI w as decreased com pared to native c^PI.
The decrease in Leu is an inexplicable result since hydrogen peroxide would
not be expected to modify this or other aliphatic residues. Statistical
analysis of the data seem s redundant, since the differences betw een
treatm ents w ere obvious, however a t-test conducted on all of th e data
revealed no new insights on the data, apart from a significant difference (P
> 0.0 5 ) in the MetSO contents of the hydrogen peroxide- vs ACT-exposed
a,Pi.
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Table 26. Comparison of amino acid residua contents of native o ^ l, or,PI
exposed to ACT and 0,1*1 exposed to hydrogen peroxide.

Percentage of total residues*

Amino
acid
residue

Lit.

Native*

Ha0 2*

ACT4

Asx

1 1 .7 0 (0.77)

13.05 (1.52)

13.82 (0.1)

1 2 .8 0 (1.50)

Glx

1 3 .6 0 (0.8)

1 4 .3 0 (1.43)

15.07 (1.09)

14 .32 (1.86)

Ser

5 .6 0 (0.53)

5 .1 4 (0.64)

4 .8 6 (0.74)

5 .1 9 (0.46)

His

3 .2 0 (-)

3 .3 2 (0.22)

3 .2 8 (0.36)

3 .0 8 (0.42)

(0 . 8 )

9 .1 3 (1.22)

8 .0 8 (1.54)

8 .5 4 (1.33)

Thr

7.47 (0.54)

8 .0 8 (1.29)

8 .8 0 (0.30)

8 .3 4 (1.15)

Ala

6 .4 0 (0,27)

7 .0 4 (0,77)

6 .9 7 (1.12)

6 .8 3 (0.95)

Arg

1.87 (0.27)

2 .0 0 (0.65)

1.66 (0.24)

2 .2 4 (0.81)

Tyr

1.60 (-)

1.26 (0.37)

1.31 (0.33)

1.53 (0.00)

Val

6 .4 0 (0.53)

7.3 8 (0.57)

7.28 (0.24)

7 .5 2 (0.45)

MetSO

-

(0 .0 0 )

0 .4 5 (0.10)

0 .8 2 (0.24)

Gly +
hSer*

8 .0 0

0 .0 0

He

5 .0 7 (0.54)

4 .9 0 (0.22)

4 .7 3 (0.10)

4 .9 2 (0.24)

Phe

7 .2 0 (0.53)

7.0 4 (0.20)

6 .8 9 (0.37)

7 .0 8 (0.57)

Leu

12.27 (1.07)

1 1.94 (0.30)

11.12 (0.40)

11.5 9 (0.48)

Lys

9 .6 0 (1.07)

9.0 3 (0.84)

8 .1 6 (0.76)

8 .4 3 (1.31)

a - Mean (s.d.). b - Sample size = 4.

c - 1.2 mM hydrogen peroxide; sample size = 5.
d - Sample size = 7. e - hSer; homoserine.
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4 , 1J2 Discussion.
The detection of MetSO in both the hydrogen peroxide- and ACTexposed a,PI is significant given the dem onstrated loss of EIC of c r, PI when
Met 3*8 is oxidized (55,72,91). Although a number of earlier reports support
the idea that Met in o r, PI is oxidized after exposure to aqueous cigarette
sm oke solutions in vitro, Met oxidation has not been directly dem onstrated
(1 2 4 ,1 3 0 ,1 3 8 ,1 4 2 ). The detection of MetSO in hydrogen peroxide-exposed
o,PI is not unexpected; MetSO formation is the primary reason for the loss
of EIC of a,PI after hydrogen peroxide exposure (260). The population of
dam aged a,PI resulting from treatm ent with hydrogen peroxide or ACT is
possibly a mixture of or, PI molecules containing none, one or more than one
MetSO. Since the hydrogen peroxide and ACT exposures result in EIC loss,
then Met 3*8 is th e residue that is oxidized predominantly. Treatm ent of a,PI
with oxidants such as Chloramine-T, IM-chlorosuccinimide and
myeloperoxidase/hydrogen peroxide/chloride results in the oxidation one to
tw o Met, namely Met 3*8 and Met361, both of which are exposed to the
solvent on the reactive site loop in a^PI (1 20 ,1 2 1,26 1). Thus, the
dem onstrated susceptibility of Met 361 to oxidation makes it reasonable that
this residue could also be oxidized in a,PI exposed to ACT, and to hydrogen
peroxide. However, it is believed that oxidation of Met 3* 1 does not affect
EIC (138,262). Other Met residues in a,PI, not accessible to the solvent,
could be oxidized after ACT or hydrogen peroxide exposure, since some
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studies have indicated th a t solvent accessibility is not necessarily a
determ inant of the susceptibility of Met residues to oxidation (263).
Although the above discussion has focused on th e oxidation of Met,
modification of Lys and Tyr residues in a,PI are known to diminish EIC,
w hereas Cys or Arg modification affect other proteinase inhibitory functions
of cr,Pt (2 1 7 ,2 1 8 ,2 5 7 ,2 6 4 ,2 6 5 ). There is no evidence from th e amino acid
analyses th a t either Lys or Tyr are affected by hydrogen peroxide or ACT
exposure. Despite the apparent absence of ch ang es to amino acids other
than Met, this does not imply that other residues are unaltered by exposure
of a,PI to hydrogen peroxide or ACT. For example, the sample treatm ent
and harsh protein hydrolysis conditions could reverse some amino acid
residue modifications, this is probably more applicable to the ACT-exposed
a,PI. Some amino acid residue modifications may be irreversible, but could
be beyond th e limit of detection of the analytical procedure.
Hydrogen peroxide at neutral or slightly alkaline pH is capable of
oxidizing thioether, sulfhydryl, imidazole, phenol and indole groups (266).
Studies with hydrogen peroxide (Table 26) show no apparent modification of
groups other than thioethers, and if other groups are modified, previously
published studies imply that they are of little importance with regard to loss
of EIC (260).
Addressing the more complex situation with ACT, we would perhaps
expect more than just modification of Met to occur. However, the amino
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acid analysis reflect no other substantial, irreversible amino acid residue
modifications (Table 26). The amino acid protection studies (section
3 .1 .2 .1 ) would imply th a t modification, irreversible or otherwise, of amine
(e-amino of Lys), aromatic (Phe), indole (Trp), guanidino (Arg) and imidazole
(His) groups, if they occur in ACT*exposed a,PI, are of no consequence with
respect to EIC loss. This conclusion necessarily assu m es that the free amino
acids have similar reactivities to the residues in their various chemical
environm ents in the protein. Interaction of a protein bound metal with
hydrogen peroxide can produce highly localized dam age affecting very few
susceptible residues, however such dam age can be devastating to protein
function (248); such relatively small changes in amino acid composition may
go undetected in the analyses presented in Table 26. Several types of
residue may undergo oxidation by this so-called "metal catalyzed oxidation'’
pathway; a contribution by this pathw ay to ACT dam age to a,PI cannot be
discounted.
In summary, the amino acid analysis results, in conjunction with the
protection data from th e free amino acid studies, su g g e st that oxidation of
Met is the primary cau se of EIC loss of a, PI exposed to ACT. Direct
oxidation of Met by hydrogen peroxide is a probable mechanism for this
modification, although metal catalyzed oxidation of Met could also be
involved. Other amino acid residue modifications can no t be disregarded, but
it is likely that such modifications are not related to the loss of EIC.
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4^2 Analysis of Native and Damaged a, PI bv Denaturing and NonDenaturina pQlvacrvlamide Gel Electrophoresis.
4 .2 .1 Experimental.
Samples of native o,PI, o,PI exposed to ACT (2.1.1.3), hydrogen
peroxide (3.2.1.21, or catechol/hydroquinone (3.2.1.4), with and without
additives w ere subjected to electrophoresis under both the denaturing and
non-denaturing conditions. The EIC values w ere determined prior to the
electrophoresis. The gels were cast in an HSI (Hoefer Scientific Instruments,
San Francisco, CA) gel casting unit and run using an HSI SE 2 5 0 vertical
slab gel electrophoresis unit. The various com ponents of the gel system s
w ere as follows, electrophoresis grade reagents w ere used throughout. The
denaturing gel had the following composition; 0 .1 % w/v SDS, 11% w/v
acrylamide, 0 .2 9 % w/v bis-acrylamide, 11 % w/v sucrose and 0 .3 7 M Tris*HCI, pH

8 .8

. The stacking gel had the following composition; 0 .1 % w/v

SDS, 3 .8 % w /v acrylamide, 0 .1 % w/v bis-acrylamide, 0 .1 3 M Tris*-HCI, pH
6 .8

. The reservoir buffer contained 0 .1 % w/v SDS, 0 .1 9 M glycine and

0 .0 2 5 M Tris*-HCI. For denaturing electrophoresis, 100

of incubate w as

mixed with 50 //I of incubation buffer and 150 ywl of sample buffer. The
samples w ere heated at 95 °C for 5 min. Blanks consisting of sample buffer
and incubation buffer only w ere also prepared in the sam e way, as were
molecular weight markers appropriately diluted from a commercial
concentrate (SDS-PAGE molecular weight standards, low range; Bio-Rad
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Laboratories, Richmond, CA). The final composition of the sample for
electrophoresis consisted of; 4 2 j/g/ml a, PI, 2% w/v SDS, 0.1 % v/v
glycerol, 0 .0 5 % v/v m ercaptoethanol, 0 .0 0 1 % w/v bromophenol blue and
0 .0 6 M Tris*-HCI, pH

6 .8

. The samples w ere cooled and 5 j/L aliquots were

applied to wells in the stacking gel. The gels w ere run in the anodal
direction, a t a stable tem perature (ca, 23 °C), using 7.5 mA/gel for the
stacking gel and 15 mA/gel for the separating gel.
The non-denaturing gels had the following composition;

8

% w/v

acrylamide, 0 .2 1 % w/v bis-acrylamide, 5.5% w/v sucrose and 0 .3 7 M Tris*HCI, pH

8 .8

. The other com ponents of the electrophoresis system w ere the

sam e as noted for the denaturing gels, except that SDS w as excluded. The
sample buffer contained neither SDS nor m ercaptoethanol.
After electrophoresis, the gels w ere immediately fixed and stained for
1

h with a solution of 50% v/v methanol, 10% v/v acetic acid and 0.1 %

w/v Coom assie Brilliant Blue R-250. After

1

h, gels w ere destained

overnight or until the background w as sufficiently clear, with 5% v/v
methanol, 7% v/v acetic acid. In most ca se s the gels w ere stained further
using a silver staining kit (Sigma Chemical Co.I to intensify th e bands. After
conditioning in 2% v/v glycerol the gels w ere dried using an HSI gel drier,
Then photographed.

137

4 ,2 ,2 Results.
The gels are displayed in Figures

8

to 13, the anode is a t th e bottom

of the gel in all cases, w here tw o lanes on the sam e gel apparently have the
sam e material in them, th e se w ere from separate incubations; only one
incubation of native or, PI w as used per experiment. Unless indicated
otherw ise, the catechol/hydroquinone incubations contained Cu(ll) and
Fe(lll).
On the SDS-PAGE gels, the native o,PI band migrated to a position
consistent with its molecular weight <52 kDa) {Fig 8-10). There w as no
detectable change in band position for the ACT or hydrogen peroxide
treatm ents, but the catechol/hydroquinone exposed a,PI show ed band
broadening with som e movement to slightly lower molecular weights
{Fig 9). Methionine and DTPA had no impact on the ACT exposed o,PI
bands (Fig 10), w hereas methionine but not DTPA caused the
catechol/hydroquinone band to "tighten" into a native o,PI band {Fig 10). In
the ab sen ce of Cu{ll) and Fe(lll) the catechol/hydroquinone exposure show ed
no difference in band structure compared to the exposures in the presence
of Cu{ll) and Fe(lll) (Fig 10).
The three types of exposure show ed different responses on the non
denaturing gels. The native o,PI consistently gave tw o bands, one more
intense and anionic than the other (Fig 1 1 - 1 3 ) . The identity of the less
anionic band is unknown; t^PI exists in tw o major isoforms in normal human
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Figure 8 . SDS-PAGE of native a,PI, a,PI exposed to ACT end a.,PI exposed
to 1.3 mM hydrogen peroxide. Gel fanes are as follows: lane 1, MW
standards; lane 2, native a,PI; lane 3, t^PI exposed to ACT; lane 4, a,PI
exposed to 1.3 mM hydrogen peroxide; lane 5, a,PI exposed to ACT; lane 6,
native a,PI; lane 7, o,PI exposed to 1.3 mM hydrogen peroxide; lane 8, MW
standards.
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Figure 9. SDS-PAGE of o tPI exposed to ACT and cr,PI exposed to
catechol/hydroquinone. Gef lanes are as follows: lane 1, MW standards;
lane 2, o,PI exposed to ACT; lane 3, a,PI exposed to catechol/hydroquinone;
lane 4, native cr,PI; lane 5, OtPI exposed to ACT; lane 6, a ,P I exposed to
catechol/hydroquinone; lane 7, native c^PI; lane 3, MW standard.
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Figure 10. SDS-PAGE of o,PI exposed to ACT and crtPI exposed to
catechol/hydroquinone in the presence of DTPA and methionine. Gel lanes
are as follows: lane 1, MW standard: lane 2, or,PI exposed to
catechol/hydroquinone [no Cu(ll) or Fe{ll)J; lane 3, c^PI exposed to
catechol/hydroquinone plus 10 mM DTPA; lane 4, a,P! exposed to
catechol/hydroquinone plus 10 mM methionine; lane 5, native o^PI; lane 6,
a, PI exposed to ACT plus 10 mM DTPA; lane 7, ^ P l exposed to ACT plus
10 mM methionine; lane 8, MW standard.
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8
t

Figure 11. Non-denaturing PAGE of native Gr-,PI, ar,PI exposed to ACT and
or,PI exposed to 1.3 mM hydrogen peroxide. Cel lanes are as follows: lane
1, native o,PI; lane 2, a^Pt exposed to ACT; lane 3. native a,PI; lane 4, c^PI
exposed to 1.3 mM hydrogen peroxide; lane 5, native o.,PI; lane 6, OtPI
exposed to ACT; lane 7, native or,PI; lane 8, o,PI exposed to 1.3 mM
hydrogen peroxide.
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Figure 12. Non-denaturing PAGE of ar,PI exposed to ACT plus catalase and
or,PI exposed to ACT under argon. Gel lanes are as follows: lane 1, a,PI
exposed to ACT plus catalase; lane 2, a, PI exposed to ACT; lane 3, a,Pt
exposed to ACT under argon; lane 4, native o,PI; lane 5, catalase; lane 6,
OtPI exposed to ACT plus catalase; lane 7, a^Pt exposed to ACT under
argon; lane 8. (^Pl exposed to ACT.

Figure 13. Non-denaturing PAGE of c^PI exposed to catechol/hydroquinone
plus 10 mM alanine, and a, PI exposed to ACT plus 10 mM amino acids.

Gel lanes are as follows: fane 7, a,PI exposed to catechol/hydroquinone;
lane 2. a,PI exposed to catechol/hydroquinone plus 10 mM Ala; lane 3,
native o,PI; lane 4, a,PI exposed to ACT; lane 5, o,PI exposed to ACT plus
10 mM Lys; lane 6, a,PI exposed to ACT plus 10 mM Arg; lane 7, o,PI
exposed to ACT plus 10 mM Met; lane 8, o,PI exposed to ACT plus
10 mM Ala.
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serum with pi values differing by 0 .2 units. It seem s unlikely that the tw o
bands represent tw o isoforms since the difference in pi is probably too small
to have an effect on mobility in these gels. The t^PI w a s used as received
from th e supplier, thus this minor band could represent the < 5 %
contamination. Since the SDS-PAGE gels gave only one band for a,PI it is
evident that the contam inant has a similar molecular weight to o,PI. The
gels were all stained with silver stain, so the less anionic band is likely
present at very low am ounts relative to the more anionic band. The results
and discussion presented in the following sections pertain to the more
intense anionic band.
Exposure of <r,PI to ACT results in smearing of the native band in the
anodal direction, indicating an increase of overall negative charge on the
protein (Fig 11-13). The hydrogen peroxide exposures have no effect on the
a,PI band position and intensity. The catechol/hydroquinone exposures also
ca u se smearing of the o,PI band toward the anode (Fig 13). Under argon, or
in the presence of catalase, the native a,PI band still sm ears tow ard the
anode; catalase is more cationic relative to c^PI and does not contain any
contam inants that co-migrate with th e a,PI (Fig 12). The effect of
catechol/hydroquinone on the electrophoretic behavior of the o,PI is mildly
reversed by 10 mM Ata (Fig 13). The effect of ACT on the electrophoretic
behavior of the o,P( is mildly reversed by 10 mM Lys, Ala, Arg or Met (Fig
13).
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4 ,2 ,3 Discussion.
The evidence so far indicates that ACT dam ages a,PI by an oxidative
mechanism, primarily oxidation of Met. In an attem pt to reproduce the
effects of ACT on a, PI the hydrogen peroxide and catechol/hydroquinone
models w ere used. The additional data from electrophoresis has
substantiated the inadequacy of the tw o models. The hydrogen peroxide
exposures account reasonably well for the MetSO formation in ACT-exposed
o,PI, but do not reproduce the non-denaturing gel changes of ACT-exposed
c^PI. On the other hand, the catechol/hydroquinone system does not show
the sam e changes as ACT-exposed a,PI on the SDS gels, but does more
closely resemble the changes on the non-denaturing gels.
The increase in the anionic nature of the o,PI exposed to ACT
indicates that ACT com ponents mask or eliminate positive charge on the
a, PI. An increase in the anionic mobility on non-denaturing gels has been
noted for o,PI exposed in vitro to whole smoke extracts (134,136). The
a, PI exposed to hydrogen peroxide does not show increased m ovem ent
tow ard the anode. Thus, oxidation of Met is not a suitable explanation for
the increase in anionic mobility. Since the incubation of a,PI with ACT plus
catalase or ACT under argon does not affect the band smearing, then
oxidative processes are probably not a involved in this increased anionic
movement on non-denaturing gels. Also, the increase in anionic behavior of
a, PI after exposure to ACT is not related to EIC loss because under argon
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ACT c a u se s th e sam e electrophoretic chan ges even though the EIC is
completely preserved (section 3.2.2 .2 ). One cannot discount, however, that
the m echanism s for the band smearing under argon are different for those
under air. The ability of 10 mM Lys, Ala or Arg to partly restore native or, PI
band character to the ACT-exposed cr^PI, yet the failure of th e se three amino
acids at 10 mM to protect against loss of EIC (section 3 .1 .2 .1 ), supports the
idea th a t the band smearing of a, PI caused by ACT is unrelated to loss of
OfPI activity. The band smearing in non-denaturing gels is possibly due to
either non-covalent interaction of ACT com ponents with positive charges on
c^PI (Lys and Arg side chains) or reversible covalent modification of Lys
and/or Arg residues. Covalent modification of 20% of the Lys residues in
o,PI (ca. 7 residues) results in a 2 0% loss of EIC, w h ereas modification of
Arg residues does not affect EIC (217). Evidently ACT com ponents do not
affect Lys residues critical to EIC, if such residues are modified by ACT
com ponents.
Alpha-1-PI exposed to catechol/hydroquinone sho w s increased
movement tow ard the anode on non-denaturing gels. In the presence of
10 mM Ala th e catechol/hydroquinone-exposed o,PI slightly more like native
a,PI. It w as suggested in section 3 .2 .3 .3 that catechol/hydroquinone may
dam age o,PI by a combination of oxidation of Met and covalent modification
of Lys. The increase in anionic behavior of the catechol/hydroquinoneexposed a,PI is consistent with modification of positively charged residues.
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The protective effect of Ala is probably due to sacrificial modification of the
o-amino group which would minimize the electrophoretic changes. Purely
oxidative chang es would not ca u se the altered mobility of
catechol/hydroquinone-exposed a,PI, since the hydrogen peroxide alone had
no effect on o,PI mobility.
On the SDS gels there is no indication of significant aggregation or
fragmentation of a,PI exposed to ACT or hydrogen peroxide. The exposure
of a,PI to catechol/hydroquinone does shift the native a,PI band to a slightly
lower molecular weight range which is indicative of fragmentation of the
a,PI. If the SDS gel changes for the catechol/hydroquinone-exposed a,PI are
indicate fragmentation then redox active metals could play a role in the
generation of species responsible for polypeptide chain scission. Hydroxyl
radicals or hypervalent transition metal species generated on, or close to, the
protein could cau se such scission and the dam age would also be dependent
on hydrogen peroxide. The addition of 10 mM DTPA to the
catechol/hydroquinone incubations does not affect the apparent
fragmentation (neither does the exclusion of the Fe(lll) and Cu(ll) additions),
suggesting the following: metals are not involved in the dam age; DTPA
cannot com pete for metals with ff,PI (at a DTPAio^PI molar ratio of 4 0 0 0 :1 ,
this is unlikely); even with DTPA present metals can still participate in
reactions such as the radical driven Fenton reaction. Adventitious metal ions
can be sufficient to ca u se protein fragmentation in the presence of hydrogen
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peroxide (249), so, even if the Cu(ll) and Fe(lll) are not added to the
incubations this may have little effect on the dam age to o,PI. The
dihydroxybenzenes are a source of reducing ability for metal ions to produce
more reactive species from hydrogen peroxide th at could fragment a, PI.
Hydroxyl radicals are produced in solutions containing catechols, DTPA and
ferric ions (254). Thus, inclusion of DTPA in the or,PI incubations with
catechol/hydroquinone does not eliminate the possibility of ROS generation.
Protein fragmentation mediated by ROS, especially those produced
site-specifically, usually results in specific fragmentation patterns, and
seldom produces complete dissolution of the protein
(2 1 5 ,2 4 3 ,2 4 8 ,2 4 9 ,2 6 7 ). The shift in the mean band position for the
catechol/hydroquinone-exposed c^PI is consistent with loss of fragm ents of
a few kDa. The changes seen for catechol/hydroquinone-exposed o^PI on
SDS gels are not related to increased anionic mobility on non-denaturing gels
since the ACT-exposed o,PI is also more anionic and yet sh o w s no change in
mobility on the SDS gels.
Unlike DTPA, 10 mM Met protects o,PI from catechol/hydroquinone
dam age and restores the mobility of c^PI on SDS gels to that of th e native
protein. The protection by methionine is m ost likely due to scavenging of
oxidants, thus preventing the generation of species th a t could fragment a, PI.
Covalent attachm ent of quinones to o,PI via amino groups, and the
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su bsequ ent reduction of the quinones, allows for localized autoxidation of
the protein-attached quinols with th e generation of ROS.
4 ,2 .4 Summ ary and future studies.
Aqueous cigarette tar extract, ca u se s a slow steady loss of the EIC of
OtPI at 37 °C, pH 7.4, to give at least a 60% loss of EIC in 2 4 h. The ACT
retains its ability to dam age flr,PI for many hours. Changes in pH and
adsorption of o,PI onto particulates are discounted as reasons for the loss of
EIC.
The dam age to o,PI by ACT is dependent on hydrogen peroxide, but
superoxide plays no direct role in the damaging mechanism. Hydroxyl
radicals or hypervalent metal species generated in the hom ogeneous phase
are not o^ l-d am ag in g species in ACT, compatible with their high reactivity
and unselectivity. The production of reactive oxygen species sitespecifically on o,PI cannot be discounted.
The loss of EIC of c^PI is due to oxidative dam age. Non-oxidative
modification does occur when or, PI is exposed to ACT, resulting in a more
anionic protein, but such modification does not cau se loss of EIC. The nonoxidative changes are not reflected in an altered content of amino acid
residues in o,PI, suggesting such changes are reversible or unrelated to
amino acid modification. Additionally, no major fragmentation of o,PI
exposed to ACT is detected. Hydrogen peroxide could account for the major
portion of dam age to ACT-exposed o,PI, by direct oxidation Met358.
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Oxidation of Met 368 is sufficient to cause a substantial loss of EIC. In
support of this, free Met but not MetSO protects against dam age to or, PI by
ACT, and ACT-exposed or,PI contains noticeable quantities of MetSO. At
concentrations relevant to those produced in ACT, hydrogen peroxide
ca u ses appreciable formation of MetSO in flr,PI and the rate of EIC loss is
comparable to that seen for ACT exposure.
Hydrogen peroxide appears to be a reasonable model for th e oxidative
changes in a, PI, but does not reproduce the non-oxidative modifications.
Exposure of o,PI to catechol/hydroquinone w as used to try to mimic the EIC
loss, non-oxidative changes and the effects of protective agents in the ACT
exposures. Catechol/hydroquinone cau ses a similar rate of EIC loss to ACT
and also increases the anionic mobility a, PI, but otherw ise this system bears
minimal resemblance to ACT. Oamage to ^ P l by catechol/hydroquinone
probably occurs by a combination of oxidation of Met and modification of
Lys.
The protective action of sulfhydryls and ascorb ate in ACT varies with
the incubation conditions, and could be due to various factors, e.g. direct
reaction with hydrogen peroxide. There are many potential roles for
transition metals in the mechanism of ACT dam age to a, PI, but none of the
chelators tested protect completely. Protection by th e chelators is probably
related to the inhibition of production, or the degradation of, hydrogen
peroxide. Removal of protein bound metals from a,PI, to inhibit metal
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catalyzed protein oxidation of Met for example, probably would not affect
the loss of EIC since hydrogen peroxide could still directly oxidize critical
methionyl residues.
Several factors need to be taken into account concerning the
potential for cigarette smoke particulate com ponents to dam age o,PI in vivo
as addressed in the following discussion. Damage to a, PI is thought to be a
highly localized event. One would not expect hom ogeneous distribution of
o,PI, antioxidants or cigarette smoke com ponents in the lung. Thus, the
ch ance for direct dam age to a, PI by cigarette sm oke com ponents is greater
at sites in the lung w here the a,PI and antioxidant concentrations are low
and the concentration of cigarette smoke com ponents is high. The detection
of very localized dam age difficult because th e bronchoalveolar lavage
techniques currently used do not enable th e sampling of lung
microenvironments.
Lung ELF is endow ed with several low molecular weight antioxidants,
such as glutathione, ascorbate and vitamin E and the variation in the am ount
of som e of th e se antioxidants in sm okers' ELF has been m easured
(268-270). Also, the ELF contains macromolecular antioxidants;
ceruloplasmin, transferrin, catalase and SOD have been detected
(26 9,2 71 ,2 72 ). The various antioxidants in ELF are likely to hinder not only
any dam age to c^PI caused by the direct action of cigarette smoke, but also
dam age due to inflammatory cell oxidants (273). Hydrogen peroxide can
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diffuse across membranes, and therefore in addition to extracellular
scavenging, hydrogen peroxide generated extracellularly can be degraded
intracellularly (137,274-276),
Cigarette smoking imposes a chronic oxidative burden on the lung. In
areas w here there is ongoing oxidative insult to the lung lining fluid, and
thus perhaps poorer antioxidant protection, cigarette smoke com ponents
would be expected to have a more direct impact on a,PI. Smokers almost
continually introduce cigarette smoke material into their lungs to replace that
which is slowly removed by the impaired clearance mechanism s. Under
normal circum stances, o^PI, HNE and elastin are present simultaneously, and
the presence of the elastin ensures that even relatively mild d ecreases in ct,PI
activity can markedly increase the degradation of elastin by HNE (72,131).
The studies in this dissertation arose from previous studies in vitro by
the Pryor research group on gas phase smoke interaction with a,PI and the
interaction of ACT with DNA. Further examination of ACT dam age to a,PI
would probably serve only to fine tune the study. Additional studies of
cigarette smoke component/o,PI interaction in vitro are probably of more use
in conjunction with in vivo studies. Human studies are beyond the
immediate scope of the Pryor group, but som e more useful human studies
await the development of substantially improved lung fluid sampling
techniques. Two further studies related to cigarette sm oke/a, PI interaction
that could be done with experimental animals are presented below.
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One of the m ost outstanding problems to date concerning the direct
interaction in vivo of c r, PI with cigarette smoke com ponents is w hether it
actually occurs! Many studies have implied that oxidation of a,PI occurs in
vivo after acu te and chronic cigarette smoke inhalation (see Chapter 1).
However, the relative contribution to such supposed oxidation from cigarette
smoke vs inflammatory cells is unknown. Those studies that sh ow no
apparent oxidation of o,PI in sm okers' lungs frequently do not discount
oxidation for a variety of reasons including poor sampling of lung
microenvironments or reluctance to discount oxidation. Unless cigarette
smoke oxidants cau se a unique and reproducible pattern of Met oxidation
then searching for oxidized o,PI is a poor way to a s s e s s its direct interaction
of cigarette smoke com ponents. One could search for evidence of some
unique protein modifications caused by cigarette smoke such as
cyanomethylation quinone addition to Lys side chains, in vitro studies are
required to d etect if authentic quinones or tho se in sm oke can react with
amino groups in a,PI.
Another avenue of in vivo research is related to determining the
macromolecular antioxidant status of lung ELF after cigarette sm oke
inhalation. Ideally, this would be done after both acu te and chronic smoke
exposures using a suitable animal model. W hereas studies of low molecular
w eight antioxidants in ELF are ongoing in other laboratories, the
macromolecular antioxidant statu s is less well studied (268,269). Part of
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the reason for this poorer study of macromolecular antioxidants in ELF is
th a t their presence has only recently been appreciated (2 7 1 ,2 7 7 ,2 7 8 ). The
ELF provides the initial antioxidant defense for the lung and so th e ability of
this fluid to diminish oxidant levels obviously places less of a burden on the
underlying cell layer as well as protecting important com ponents of the ELF.
Since the macromolecular antioxidants are proteins their function could be
impaired by the action of cigarette smoke and inflammatory cell-derived
oxidants. This study unfortunately suffers from the sam e problem of
microenvironment sampling, but this has not hindered the acquisition of
useful data on the low molecular weight antioxidants.
Obviously the best preventative m easure for cigarette smoke-induced
disease is not to smoke, but this approach has evidently failed in numerous
cases. Since cigarette smoking is unlikely to disappear in the near future,
continued research on the chemistry of cigarette smoke and the pathological
m echanism s of cigarette smoking-induced disease is justified. Smoking is a
major public health problem that proves costly both in term s of life and
healthcare. Research into the basic m echanisms of smoking-induced disease
should ultimately enable the development of suitable m easures to reduce the
risk to sm okers' and non-smokers' health, until such a time as the smoking
habit is abandoned.
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APPENDICES

APPENDIX A

AlphajPI, or c^PI - Alpha-1-proteinase inhibitor.
ACT - Aqueous cigarette tar extract.
AM - Alveolar macrophage(s).
Av.dev. - Average deviation.
BPTI - Bovine pancreatic trypsin inhibitor.
BSA - Bovine serum albumin.
DDC - Diethyldithiocarbamate.
DGP - Direct gas phase.
DTPA - Diethylenetriamine pentapentaacetic acid.
DTT - Dithiothreitol.
EDTA - Ethylenediamine tetraacetic acid.
EGTA - (Ethylenedioxy)diethylenenitrilo tetraacetic acid.
EIC - Elastase inhibitory capacity.
ELF - Epithelial lining fluid.
ESR - Electron spin resonance spectroscopy.
GPE - Gas phase extract.
GSH - Glutathione.
GSSG - Oxidized glutathione.
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HIMDA * N-(2-hydroxyethyl)iminodiacetic acid.
HNE - Human neutrophil elastase.
HPLC - High pressure liquid chromatography.
MetSO - Methionine sulfoxide.
NE - Neutrophil elastase.
PMN - Polymorphonuclear leukocyte(s); neutrophil(s).
PPE - Porcine pancreatic elastase.
ROS - Reactive oxygen species.
SANA - N-succinyl-(L*Ala) 3-p-nitroanilide.
s.d. - Standard deviation.
SOD - Superoxide dismutase.
TPM - Total particulate m atte-.
X/XO - Xanthine/xanthine oxidase.
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